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Unlike mammals, zebrafish have a remarkable capacity to regenerate the central 
nervous system. Following neuronal loss by physical injury or chemical ablation 
zebrafish are capable of replacing neurons through increased neurogenesis, resulting 
in functional recovery. 
In the adult zebrafish brain, certain populations of dopaminergic and noradrenergic 
neurons, identified by immunohistochemistry for tyrosine hydroxylase (Th+), are 
regenerated after ablation with 6-hydroxydopamine (6OHDA), an analogue of 
dopamine commonly used to specifically ablate these neurons. Here I ask where 
these newly formed Th+ neurons originate and which signals are involved in their 
regeneration.  
In the adult zebrafish new neurons are derived from progenitor cells, the soma of 
which form part of the ependyma and which have radial processes extending to the 
pial surface, termed ependymo-radial glial cells (ERGs). In this thesis I show that 
ERGs lining the diencephalic ventricle are a heterogeneous population in terms of 
expression of her4, gfap, and olig2. Using genetic lineage tracing and proliferation 
analysis I demonstrate that regenerated Th+ neurons are derived from specific ERGs 
at the diencephalic ventricle.  
In contrast to mammals, Th+ neurons are constantly generated in the adult zebrafish 
brain. Here I show that injection of 6OHDA elicits an immune response, and that 
inhibiting this immune response with the artificial glucocorticoid dexamethasone 
attenuates proliferation of ERGs and neurogenesis of Th+ neurons to control levels. 
Although stimulating an immune response increases proliferation of ERGs, an 
immune response is not sufficient to increase Th+ neurogenesis.  This demonstrates 
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that an immune response is necessary but not sufficient for the regeneration of Th+ 
neurons in the adult zebrafish brain.  
Following a spinal cord lesion, both larvae and adult zebrafish are capable of 
functional regeneration.  Spinal cord regeneration has been shown to involve 
increased neurogenesis of motor neurons; however, the extent to which other 
neuronal populations are regenerated has not been fully elucidated. Here I show that 
glutamatergic neurons are regenerated after a spinal cord lesion in larvae, and 
GABAergic neurons are regenerated in both larvae and adults.      
Taken together, these results provide new insights into the regeneration of the central 
nervous system in zebrafish. I identify populations of neurons which are regenerated, 
progenitor cells that give rise to regenerated neurons, and I demonstrate the pivotal 
role of the immune response in modulating regeneration. These results could 
















In adult mammals, including humans, new nerve cells (neurons) are very rarely 
produced in the brain and spinal cord. When neurons die, for example as a result of 
an injury or a neurodegenerative disease (e.g. Parkinson’s disease), these cells are 
not replaced. This leads to lifelong debilitating conditions with little chance of 
improvement.  In contrast, zebrafish are able to regenerate neurons in the brain and 
spinal cord even into adulthood.  
Parkinson’s disease is caused by the death of a specific type of neuron called 
dopaminergic neurons. In zebrafish, we can kill dopaminergic neurons by injecting a 
toxin into the brain. In some areas of the brain, these neurons are then replaced. In 
this thesis I show where these new neurons come from, identifying a specific type of 
cell in a particular area of the brain. 
Injection of the toxin elicits a response from the immune system. Inhibiting this 
immune response reduces the number of new dopaminergic neurons formed. Unlike 
mammals, zebrafish are constantly producing new dopaminergic neurons, but 
stimulating an immune response did not increase the number of new dopaminergic 
neurons formed above the normal levels. This means that activation of the immune 
system is necessary for the replacement of dopaminergic neurons, but stimulating the 
immune system alone, without killing neurons, is not enough to increase the 
production of dopaminergic neurons in the brain. Hence, additional signals are 
needed for successful regeneration. 
In mammals, spinal cord injury can lead to permanent paralysis. However, zebrafish 
are able to repair their spinal cord and regain normal swimming capacity. Repairing 
the spinal cord involves the replacement of neurons which have been lost; however, 
it is not known whether all the different types of neurons in the spinal cord can be 
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replaced. Here I show that two types of neurons (glutamatergic neurons and 
GABAergic neurons) are both replaced after a spinal cord lesion.  
Taken together, these results provide new insights into the regeneration of the brain 
and spinal cord in zebrafish. I demonstrate the types of neurons which can be 
replaced, where new dopaminergic neurons come from in the brain, and the pivotal 
role of the immune system in the replacement of dopaminergic neurons. These results 
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Chapter One: General Introduction 
1.1 The scope of the study 
The mammalian central nervous system has a remarkably poor natural ability to repair 
and regenerate (Gage & Temple 2013). Through the investigation of successful 
regeneration in other species, such as zebrafish, we can gain insights into how 
neurons can be replaced in the adult brain and spinal cord (Kaslin et al. 2008; Zupanc 
2009; Sîrbulescu & Zupanc 2011; Becker & Becker 2015).  
In the adult zebrafish brain, certain populations of dopaminergic neurons, identified 
by immunohistochemistry for tyrosine hydroxylase (Th+), are regenerated after 
ablation (Vijayanathan et al. 2017; Caldwell et al. 2018). In addition, both larval and 
adult zebrafish are capable of regeneration following a spinal cord lesion, and this 
involves the replacement of lost neurons through neurogenesis (Becker et al. 2004; 
Reimer et al. 2008; Ohnmacht et al. 2016).   
In this thesis I investigate the source of newly generated Th+ neurons in the adult 
zebrafish brain and the signalling mechanisms involved in their regeneration. I then 
investigate a number of different methods used to ablate dopaminergic neurons and 
evaluate their success in ablating Th+ populations in the zebrafish brain. Lastly, I 
investigate the extent to which glutamatergic and GABAergic neurons in the spinal 
cord are regenerated following a spinal cord lesion.  
In order to achieve this, in chapter 3 I investigate the origin of newly generated Th+ 
neurons in the adult zebrafish brain. I describe the heterogeneity of cells lining the 
diencephalic ventricle and use genetic lineage tracing to show that new Th+ neurons 




In chapter 4 I investigate the signalling pathways involved in the regeneration of Th+ 
neurons. I show that the ablation of Th+ neurons elicits an immune response. I then 
ask whether this immune response is necessary and/or sufficient for the successful 
regeneration of Th+ neurons. Furthermore, I investigate the involvement of particular 
signalling molecules in the regeneration of Th+ neurons, including leukotriene C4, tnf-
α, and dopamine.  
Thirdly, in chapter 5 I investigate three methods to ablate Th+ neurons. I evaluate the 
extent of Th+ cell loss in pink1-/- zebrafish compared to wildtype fish, in chemogenetic 
ablation of dopaminergic neurons, and in fish injected with MPTP and MPP+.      
Chapter 6 focusses on the regeneration of interneurons following a spinal cord lesion. 
I investigate whether glutamatergic and GABAergic neurons are replaced following a 
lesion in both larval and adult zebrafish by comparing the levels of neurogenesis in 
unlesioned fish to lesioned fish.  
In summary, I demonstrate which populations of neurons are capable of being 
regenerated in the zebrafish central nervous system, which cells give rise to 
regenerated neurons, and the signalling pathways involved in their regeneration. 
These results could ultimately inform future attempts to promote neuroregeneration 
in mammals. 
1.2 The regenerative capacity of the mammalian central nervous system 
In mammals, the natural capacity for regeneration of the central nervous system (CNS) 
is relatively poor when compared to other vertebrates (Gage & Temple 2013). This 
means that neurons lost as a result of disease or damage to the CNS are not replaced, 
leading to lifelong impairments. In particular, in this thesis I will focus on dopaminergic 




The successful regeneration of these neurons in humans would revolutionise the 
treatment of diseases and injuries concerning the brain and spinal cord (Barker et al. 
2018).  
1.2.1 Cell replacement therapies improve functional recovery in Parkinson’s 
disease and after spinal cord injury 
Parkinson’s disease is the second most common neurodegenerative disease, 
affecting an estimated 1% of the world’s population over 60 years of age (de Lau & 
Breteler 2006). The disease is characterised by a selective loss of dopaminergic 
neurons in the substantia nigra, which are progressively lost and not replaced 
(Fearnley & Lees 1991; Cheng et al. 2010). This causes a dopamine deficiency in the 
basal ganglia, leading to debilitating motor and non-motor symptoms (Kalia & Lang 
2015). The treatment options for Parkinson’s disease are focussed on symptom 
management rather than disease modification. Current treatments are not effective in 
all patients and prolonged treatment leads to a loss of efficacy  (Connolly & Lang 2014; 
Toda et al. 2016).  
A number of pioneering cell replacement techniques have been trialled in patients 
with Parkinson’s disease, as neuronal loss is largely limited to one neuronal subtype 
in one location (Barker et al. 2015). Developing midbrain dopaminergic neurons 
extracted from human foetal ventral midbrain can be transplanted into the brains of 
patients. These trials have delivered highly variable results, but significant 
improvements have been reported in patients at several different centres (Li et al. 
2016; Kefalopoulou et al. 2014; Hauser et al. 1999). This demonstrates a proof of 
concept that replacing the lost dopaminergic neurons can provide long-lasting 
benefits to patients. However, the use of foetal tissue carries a number of technical 
and ethical limitations (Turner & Kearney 1993), not least because the demand for 




Recent advances in protocols to differentiate human embryonic stem cells and 
induced pluripotent stem cells into midbrain dopaminergic neurons have provided a 
readily available, robust source of cells for transplantation (Steinbeck & Studer 2015). 
Transplantation of these cells into rodent and non-human primate models of 
Parkinson’s disease demonstrated their ability to survive and innervate the correct 
target structures (Kriks et al. 2011; Grealish et al. 2014; Kikuchi et al. 2017). 
Importantly, the cells integrate into the existing neuronal circuitry (Grealish et al. 2015), 
and have been shown to improve the animal’s performance in motor tasks, 
demonstrating functional recovery (Kriks et al. 2011; Steinbeck & Studer 2015). As a 
result, a number of clinical trials are currently ongoing and planned for the near future 
to determine whether the transplantation of these cells offers an efficacious and safe 
treatment for Parkinson’s disease.  
Despite the advancement in cell replacement therapies, there are limitations 
associated with the transplantation of cells into the brain. Human foetal neurons and 
human embryonic stem cells both have the disadvantage that they can lead to 
transplant rejection, and there are ethical concerns attached to the use of human 
embryonic tissue (Stoker et al. 2017; Turner & Kearney 1993). On the other hand, the 
variability in the response of each individual cell line to differentiation protocols means 
that each graft of patient-specific induced pluripotent stem cells would be subject to 
regulatory approval, resulting in a likely prohibitive financial hurdle for a large-scale 
treatment (Stoker et al. 2017). An alternative to these approaches is to use fibroblasts 
which have been directly reprogrammed to dopaminergic neuron-like cells, minimising 
the risk of the transplanted cells developing into tumours by avoiding the pluripotent 
stage (Marro et al. 2011, Parmer et al. 2018). Although this is a promising new 
approach, there is a lack of studies showing the long-term survival of these neurons 




transplants could contain unwanted cell types (Parmer et al., 2018). Hence, there is 
significant interest in promoting the production of new dopaminergic cells from 
endogenous neural progenitor cells in the brain, thus harnessing the intrinsic 
neurogenic potential of the human brain for a possible treatment for Parkinson’s 
disease (Lamm et al. 2014).  
Spinal cord injuries can result in severe and lifelong disabilities, dramatically reducing 
quality of life. At present, treatment options are primarily physiotherapy, surgical 
procedures to stabilise the spinal cord, and the anti-inflammatory drug 
methylprednisolone (Silva et al. 2014; Baptiste & Fehlings 2007). However, these 
interventions offer limited hope for functional recovery (Silva et al. 2014; Baptiste & 
Fehlings 2007).  
Spinal cord injuries cause neuronal death, and in the mammalian spinal cord these 
cells are not replaced, despite the presence of neural stem cells which can be 
propagated in vitro (Weiss et al. 1996; Shihabuddin et al. 1997; Meletis et al. 2008). 
Transplantation of stem cells into the injured rodent spinal cord has been shown to 
improve functional recovery (Hofstetter et al. 2005; Ogawa et al. 2002), partly due to 
the replacement of cells which have been lost as a result of the injury (Meletis et al. 
2008; Ogawa et al. 2002). It is therefore of interest to investigate how endogenous 
stem cells might be used to replace neurons in order to develop new therapies for 
humans with spinal cord injuries.  
1.3 Zebrafish as a model for successful regeneration of the CNS  
Unlike mammals, zebrafish have a remarkable capacity for CNS regeneration 
(Reimer et al. 2008; Ogai et al. 2014; Ming & Song 2011; Goldshmit et al. 2012; 
Becker & Becker 2008; Becker & Becker 2015; Gemberling et al. 2013; Ghosh & Hui 




lesions can be regenerated, including all major retinal cell types (Goldman 2014). 
After a stab lesion to the telencephalon or injection of neurotoxic substances into the 
brain constitutive neurogenesis is significantly increased to replace the neurons which 
have been lost (Kroehne et al. 2011; Kyritsis et al. 2012; Skaggs et al. 2014; Bhattarai 
et al. 2017). Following a spinal cord injury motor neurons, pax2 expressing 
interneurons, V2 interneurons, and serotonergic interneurons are all replaced as a 
result of injury-induced neurogenesis (Reimer et al. 2008; Kuscha, Barreiro-Iglesias, 
et al. 2012; Kuscha, Frazer, et al. 2012; Hui et al. 2010). This ability to regenerate 
neurons in all regions of the CNS after a variety of different insults has inspired 
research into the mechanisms involved in the successful regeneration of the zebrafish 
CNS.  
In addition to their capacity of CNS regeneration, zebrafish have become a commonly 
used model to study regeneration of the nervous system for a number of reasons. 
Firstly, zebrafish are vertebrates and therefore share more similarities with mammals 
than invertebrate model organisms with high regenerative capacity, such as 
planarians (Orii et al. 2005). The processes which regulate development of the 
nervous system are highly conserved among vertebrates (Lieschke & Currie 2007), 
and CNS regeneration in zebrafish has been shown to recapitulate some of the 
processes which occur during development (Becker & Becker 2015). Furthermore, 
the value of zebrafish as a tool for developing new therapeutic strategies for the 
human CNS has precedent. A chemical screen in zebrafish identified compounds 
which have subsequently been taken forward into clinical trials in patients with Dravet 
syndrome, a severe childhood epilepsy, and these trials have so far reported 
promising results (Griffin et al. 2017). Therefore investigations into the successful 
regeneration of the zebrafish CNS could provide insights which lead to new strategies 




Secondly, the zebrafish genome has been sequenced completely and published as a 
well-annotated reference genome. The genetic accessibility of zebrafish means that 
targeted mutagenesis techniques such as Tol2 mutagenesis and CRISPR/Cas9 can 
be employed to precisely manipulate particular genes. This can be used to investigate 
the role of particular genes in neuroregeneration by assessing the consequences of 
underexpression or overexpression of genes of interest (Simone et al. 2018; Auer & 
Del Bene 2014; Halpern et al. 2008; Hans et al. 2009; Kwan et al. 2007). 
Furthermore, zebrafish lay clutches with up to several hundred offspring, increasing 
the sample size and improving the robustness of results in experiments using 
embryos and larvae. This has led to the development of medium throughput screening 
technologies, where hundreds of zebrafish can be imaged automatically within a few 
hours (Hao et al. 2010; Hong 2009; Pfriem et al. 2012; Spomer et al. 2012). 
Moreover, there are a large number of fluorescent reporter lines available, and new 
transgenic reporter fish can be easily created. Developing zebrafish are translucent 
up to a few days post fertilisation, and their size means the entire brain or spinal cord 
can be observed in reasonable detail when placed under a microscope. This obviates 
the need for sectioning and thus makes developing zebrafish particularly amenable 
to live imaging (Higashijima et al. 2003; Feierstein et al. 2015). This is an invaluable 
tool in investigating the dynamic processes involved in regeneration of the CNS. 
Furthermore, the size of the adult brain renders it relatively accessible for live imaging, 
and this has already led to new insights into stem cells in the adult brain (Dray et al. 





1.4 Neurogenesis in the adult zebrafish CNS in comparison to the 
mammalian CNS 
Regeneration of the CNS is a complex process involving clearance of dead and 
damaged cells, the replacement of neurons, and the regrowth of severed axons and 
re-innervation of their target structures, culminating in functional recovery (Zupanc 
2009; Zupanc 2001; Becker & Becker 2015; Sofroniew 2018). In this thesis I focus on 
increased neurogenesis in the damaged CNS, a mechanism to replace neurons which 
have been ablated or lost as a result of injury.   
The production of new neurons, neurogenesis, occurs in the intact adult CNS, albeit 
to a vastly different degree depending on the species (Kaslin et al. 2008; Grandel & 
Brand 2013; Gage & Temple 2013; Zupanc & Sîrbulescu 2011). It has been 
suggested that the success of CNS regeneration in a species correlates to the number 
of proliferative zones present in the CNS (Grandel et al. 2006). Progenitor cells in 
these zones proliferate to generate new cells, which can differentiate into neurons, 
migrate away from the proliferative zone, and integrate into the existing circuitry.  
In the human CNS neurogenesis is believed to be confined to two regions of the brain: 
the subventricular zone (SVZ) of the lateral ventricles in the telencephalon and the 
subgranular zone (SGZ) of the dentate gyrus in the hippocampus (Eriksson et al. 1998; 
Bergmann et al. 2015). However, even the production of new neurons in these two 
areas remains controversial due to the limitations of working with human subjects 
(Sorrells et al. 2018; Lee et al 2018).  
Although the existence and extent of adult neurogenesis in humans is still a matter of 
debate, there is a substantial amount of literature identifying new neurons in other 
mammals (Ming and Song 2011; Bergmann et al. 2015). In rodents, neurogenesis 




Das 1965; Altman 1969; Bergmann et al. 2015). Newly generated cells in the SVZ 
migrate along the rostral migratory stream to the olfactory bulb where they contribute 
to the constant turnover of interneurons in the olfactory bulb (Merkle et al. 2007). The 
majority of neuroblasts in the SVZ do not mature into differentiated neurons, and only 
a small percentage integrate into the circuitry of the olfactory bulb (Biebl et al. 2000; 
Winner et al. 2002). Newly generated cells in the SGZ migrate the relatively short 
distance to the granular cell of the dentate gyrus, where they integrate into the existing 
circuitry and show functional electrophysiological properties (Cameron et al. 1993; 
Seri et al. 2001; Seri et al. 2004; van Praag et al. 2002).  
Analysis of the proliferative zones in the adult zebrafish brain identified 16 distinct 
zones with constitutive proliferation, and these domains were located along the entire 
rostral-caudal axis, including in the telencephalon, preoptic region, thalamus, 
hypothalamus, midbrain and cerebellum (Grandel et al. 2006). These zones 
contained label-retaining cells at the ventricle, and the majority of the progeny 
generated from these cells differentiate into neurons (Zupanc et al. 2005; Grandel et 
al. 2006), indicating that these are self-renewing neural progenitor cells. At least in 
the telencephalon these cells are the source of a number of different neuronal 
subtypes, including GABAergic neurons, dopaminergic neurons, and 
parvalbuminergic neurons (Adolf et al. 2006; Grandel et al. 2006; Skaggs et al. 2014).  
Comparing the numbers of cells labelled with the thymidine analogue BrdU (5-bromo-
2'-deoxyuridine) as provided quantitative comparisons between the numbers of cells 
generated in the adult rodent brain and the zebrafish brain. BrdU intercalates into 
DNA during S phase, labelling proliferating cells and their progeny. The number of 
BrdU+ cells indicate that the level of cell proliferation in the zebrafish CNS is at least 
one, potentially two, orders of magnitude greater than the adult rodent CNS (Zupanc 




However, it should also be noted that there are also examples of regions of the CNS 
which can successfully regenerate in some species, but which have little or no 
constitutive neurogenesis.  Examples include the adult zebrafish spinal cord and the 
salamander midbrain (Becker et al. 2004, Berg et al. 2010). This demonstrates that 
although there may be a correlation between the number of proliferation zones and 
the regenerative ability of the CNS in a species, constitutive proliferation of progenitor 
cells is not a prerequisite to neuroregeneration.   
1.5 Regeneration of dopaminergic neurons in the adult zebrafish brain  
As discussed previously, Parkinson’s disease is characterised by a selective loss of 
dopaminergic neurons which are never replaced. This has inspired research into the 
regenerative capacity of dopaminergic neurons specifically in animals with a higher 
regenerative capacity than mammals, including zebrafish.  
1.5.1 Dopaminergic neuron populations in the adult zebrafish brain 
Tyrosine hydroxylase (Th) catalyses the rate limiting step in the synthesis of 
catecholamines, and therefore serves as a reliable marker of dopaminergic and 
noradrenergic cells (Pickel et al. 1975; Hökfelt et al. 1976). The Th antibody used to 
identify Th+ neurons throughout this thesis has been found to be highly specific (Chen 
et al. 2009). 
The adult zebrafish brain contains 17 distinct populations of dopaminergic and 
noradrenergic neurons (Figure 1. 1). Throughout this thesis I will refer to the Th+ 
populations in the zebrafish brain by the nomenclature suggested by Sallinen et al. 
(Sallinen et al. 2009), which numbers Th+ populations according to their rostral-caudal 





Figure 1. 1 Schematic illustrating the 17 distinct populations of Th+ neurons in the adult zebrafish 
brain, using the nomenclature suggested by Sallinen et al. 2009. Noradrenergic cells are indicated 
in blue (in the locus coeruleus and population 15/16), while dopaminergic neurons are indicated 
in red (all populations listed except the locus coeruleus).    
Notably, there are no dopaminergic neurons in the zebrafish midbrain. However, 
tracer studies have shown that the ascending projections of population 11 in the 
ventral diencephalon project to the subpallium of the telencephalon, suggesting that 
these projections are equivalent to the nigrostriatal pathway in mammals. Therefore, 
population 11 is the strongest candidate population of Th+ cells for a zebrafish 





1.5.2 6-hydroxydopamine-induced ablation of Th+ neurons in the adult 
zebrafish brain  
In order to study the regeneration of Th+ neurons a method is required to specifically 
ablate these neurons in the otherwise intact brain. 6-hydroxydopamine (6OHDA) is 
one of the most commonly used methods to ablate dopaminergic neurons. Injection 
of 6OHDA has been used since the 1960s (Ungerstedt 1968) to successfully ablate 
dopaminergic neurons in the adult brain in non-human primates (Eslamboli 2005), 
rodents (Deumens et al. 2002), amphibians (Berg et al. 2010), planarians (Nishimura 
et al. 2011) and zebrafish (Matsui et al. 2017; Vijayanathan et al. 2017; Caldwell and 
Davies et al. 2018).  
6OHDA is a structural homologue of catecholamines dopamine and noradrenaline, 
and as such can enter cells via the dopamine transporter (dat) and the noradrenaline 
transporter (nat) (Van Kampen et al. 2000; Jackson-Lewis et al. 2012; Bové & Perier 
2012). Once inside these cells, 6OHDA undergoes auto-oxidation generating 
cytotoxic species including H2O2, reactive oxygen species (ROS), and catecholamine 
quinones (Padiglia et al. 1997; Palumbo et al. 1999). Cytotoxic species are also 
produced in part through oxidation by monoamine oxidase (MAO-A), generating 
hydrogen peroxide, H2O2, which triggers the production of oxygen radicals (Cohen 
1984). Hence, 6OHDA-mediated neurotoxicity is a result of oxidative stress (Simola 
et al. 2007).  
In the adult zebrafish brain, our group and others have shown that a single injection 
of 6OHDA is sufficient to ablate dopaminergic neurons (Caldwell and Davies et al. 
2018; Vijayanathan et al. 2017; Matsui et al. 2017). A previous PhD student in our 
group, Nick Davies, compared the numbers of Th+ profiles in fish injected with 6OHDA 
to sham injected controls. He found a 51% reduction in the number of Th+ neurons in 




loss of Th+ neurons in the locus coeruleus (LC) after 6OHDA (Figure 1. 2B, (Caldwell 
and Davies et al. 2018)). Two other studies also reported a 6OHDA-induced reduction 
in the number of Th+ neurons in the posterior tuberculum (populations 11 and 12) and 
locus coeruleus (Matsui et al. 2017; Vijayanathan et al. 2017).  
 
Figure 1. 2 Specific populations of Th+ neurons are ablated by 6OHDA. A: A schematic sagittal 
section of the adult brain is shown with the 6OHDA resistant dopaminergic cell populations (red) 
and the vulnerable dopaminergic (green) and noradrenergic populations (purple) in relation to 
the injection site in the third ventricle indicated. B: Quantification of cell loss after toxin injection 
at 2 dpi is shown. C: Sagittal sections of population 5/6 are shown in a dat:GFP transgenic fish. 
This shows elevated local TUNEL and microglia labelling in population 5/6 after ablation. Some 
microglial cells that have engulfed TUNEL and GFP positive cell fragments are depicted by 
arrowheads. D: A high magnification is shown of a TUNEL+/dat:GFP+ and orthogonal views). E: 
Injection of the toxin decreases levels of dopamine (DA), increases levels of the metabolite 
DOPAC, but leaves serotonin (5-HT) and metabolites (5-HIAA, 3-MT) unaffected, as shown by 
HPLC. Student’s T- test (with Welch’s correction for heteroscedastic data) and Mann Whitney-U 
tests were used for pairwise comparisons in B and D (*p < 0.05; ** p < 0.01; *** p < 0.001). Bar in 
C = 50 µm, in D = 5 μm. Figure is reproduced from (Caldwell and Davies et al. 2018). 
In line with a reduction in the number of Th+ neurons, we found that 6OHDA induced 




for dopaminergic neurons, Tg(slc6a3:EGFP), abbreviated to dat:GFP (Xi et al. 2011) 
(Figure 1. 2C and D, (Caldwell and Davies et al. 2018)). Double positive 
TUNEL+/GFP+ cells were observed only in ablated populations and only in areas 
labelled by the transgene. This was accompanied by a 45% reduction in the level of 
dopamine, but not serotonin or its metabolites, in the brain after 6OHDA injection 
(Figure 1. 2E, (Caldwell and Davies et al. 2018)).  
1.5.3 Th+ neurons are replaced as a result of increased neurogenesis 
The numbers of Th+ neurons in populations affected by 6OHDA were counted at 
several time points after 6OHDA injection. The number of Th+ profiles in population 
5/6 was increased at 42 dpi compared to 2 dpi, and had returned to control levels by 
180 dpi (Figure 1. 3, (Caldwell and Davies et al. 2018)). Despite a transient increase, 
the numbers of Th+ profiles in population 12 and the locus coeruleus never fully 
recovered, indicating a differential potential for cell replacement among Th+ 
populations in the adult zebrafish brain. Similarly, the axonal projections of population 
12 and the locus coeruleus to the spinal cord were never recovered following 6OHDA-
induced ablation, even at 540 dpi (Caldwell and Davies et al. 2018). The projections 
from neurons in these two populations comprise the Th+ innervation of the spinal cord, 
so an absence of Th+ axons in the spinal cord can be used as an indication of 






Figure 1. 3 Replacement of Th+ neurons differs between brain nuclei. Sagittal brain sections are 
shown; dorsal is up, rostral is left. Some Th+ cell bodies are indicated by arrowheads. A-E: In 
population 5/6 the number of Th+ cells is reduced after toxin-induced ablation and back to levels 
seen in controls without ablation by 180 dpi. F-J: In population 12, a partial and transient recovery 
in the number of Th+ cells was observed at 42 dpl. K-O: In the LC there was also a partial and 
transient recovery of Th+ cell number. Two-way ANOVA (p < 0.0001) with Bonferroni post-hoc test 
(*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001) for E, J, and O. Bars = 50 µm. Figure is reproduced 
from (Caldwell and Davies et al. 2018).  
Th+ neurons are constantly generated in the adult zebrafish brain, as demonstrated 




days post BrdU injection (Grandel et al. 2006). To determine whether Th+ cell 
numbers recovered as a result of increased neurogenesis, Nick Davies examined the 
number of new Th+ neurons in 6OHDA-injected fish compared to sham-injected fish. 
EdU was injected daily for seven consecutive days after 6OHDA injection, and the 
number of Th+/EdU+ cells was counted at 42 days post injection of 6OHDA. Double 
labelled cells were observed in sham injected fish in populations 5/6, 8, and 11, 
demonstrating that neurons in these populations are constitutively generated (Figure 
1. 4, (Caldwell and Davies et al. 2018)). A 4.9 fold increase was found in the number 
of newly generated Th+ neurons in population 5/6 after 6OHDA injection. Meanwhile, 
no Th+/EdU+ cells were observed in population 12 and the locus coeruleus, either in 
control or 6OHDA-injected fish. Therefore the differences in Th+ neuron replacement 





Figure 1. 4 Generation of new Th+ cells is enhanced by prior ablation only in dopaminergic 
populations showing constitutive neurogenesis. A: The experimental timeline is given. B,C: In 
sagittal sections of population 5/6 (rostral left; dorsal up), EdU and Th double-labelled cells can 
be detected. Boxed areas are shown in higher magnifications in B’-C’’’, indicating cells with an 
EdU labelled nucleus, which is surrounded by a Th+ cytoplasm (arrowheads). D: A high 
magnification and orthogonal views of an EdU+/Th+ cell after 6OHDA treatment is shown. E-I: 




nuclei (E-G). After 6OHDA treatment, a statistically significant increase in the number of these 
cells was observed for population 5/6. Note that population 12 and LC showed no constitutive or 
ablation-induced EdU labelled Th+ cells (H, I). (Student’s T-tests with Welch’s correction, *p 
<0.05,). Bar in C = 20 µm for A,B; bar in C’’’ = 5 µm for B’- C’’’, bar in D = 10μm. Figure is reproduced 
from (Caldwell and Davies et al. 2018). 
1.6 Successful regeneration of the zebrafish spinal cord 
Following complete transection of the spinal cord adult zebrafish are able to recover 
function and regain normal swimming capacity by six weeks post lesion (Becker et al. 
2004; Reimer et al. 2008). Regeneration of the spinal cord involves the replacement 
of lost neurons and the regrowth of severed axons across the lesion site. In the 
unlesioned spinal cord, progenitor cells are essentially quiescent, demonstrated by 
very low numbers of PCNA+ and BrdU+ cells around the central canal (Reimer et al. 
2008). However, a spinal cord lesion induces a substantial increase in cellular 
proliferation in cells around the central canal (Takeda et al. 2008; Reimer et al. 2008). 
These proliferating cells include neural progenitor cells proximal to the lesion site, 
shown by an increase in PCNA+ and BrdU+ cells at the ventricle from 3 -14 dpl (Reimer 
et al. 2008). By 14 dpl new motor neurons can be found close to the site of injury 
(Reimer et al. 2008). At this time point there is also a 24-fold increase in the number 
of vsx1+ interneurons and a 3-fold increase in the number of 5-HT interneurons, in 
comparison to the unlesioned spinal cord (Kuscha, Barreiro-Iglesias, et al. 2012).  
Spinal cord regeneration can also be observed in larval zebrafish (Briona & Dorsky 
2014a; Ohnmacht et al. 2016). This system recapitulates aspects of the adult 
zebrafish spinal cord lesion, but on a shorter time scale. Larval zebrafish lesioned at 
3 days post fertilisation (dpf) can regenerate their spinal cord and recover normal 
swimming behaviour by 2 dpl (Ohnmacht et al. 2016). The number of newly generated 
motor neurons is increased at 2 dpl compared to unlesioned age-matched controls 
(Ohnmacht et al. 2016), demonstrating that there is a lesion-induced increase in 




1.7 Statement of aims 
• To investigate the origin of new Th+ neurons in the adult zebrafish brain 
• To investigate the signalling pathways involved in the regeneration of Th+ 
neurons  
• To investigate alternative methods of Th+ neuron ablation 
• To investigate the regeneration of glutamatergic and GABAergic neurons in 










Chapter Two: Materials and Methods 
2.1 Zebrafish husbandry and lines 
Zebrafish (Danio rerio) were housed under standard conditions (Westerfield 2000) 
including a 14/10 hour light/dark cycle, with their water carefully monitored to maintain 
a constant temperature, salinity, and pH. Embryos were collected within 2 hours of 
fertilisation and raised in fish water with 0.00001% methylene blue at 28.5°C until 5 
dpf. All experimental procedures were approved by the British Home Office.  
The fish lines I used were: wild type (WIK and TL, as indicated); Tg(gfap:GFP), 
abbreviated as gfap:GFP (Bernardos & Raymond 2006); Tg(olig2:DsRed2), 
abbreviated as olig2:DsRed (Kucenas et al. 2008); Tg(her4.3:EGFP), abbreviated as 
her4:GFP (Yeo et al. 2007); Tg(her4.1:TETA-GBD-2A-mCherry), abbreviated as 
her4:mCherry (Knopf et al. 2010); irf8st95/st95, abbreviated as irf8-/- (Shiau et al. 2015); 
Tg(pink1sh391:sh397), abbreviated as pink1-/- (Flinn et al. 2013); Tg(otpb.A:nfsB–egfp), 
abbreviated as otpb:NTR-GFP (Lambert et al. 2012); Tg(gad1b:loxP-RFP-loxP-
EGFP), abbreviated as gad1b:RFP (Satou et al. 2013); Tg(vglut2a:loxP-RFP-loxP-
EGFP), abbreviated as vglut2a:GFP (Satou et al. 2013). For genetic lineage tracing I 
used Tg(-3her4.3:Cre-ERT2) (Boniface et al. 2009) crossed with Tg(actb2:LOXP-
mCherry-LOXP-EGFP) (Ramachandran et al. 2010), as previously described (Skaggs 
et al. 2014). Note that zebrafish nomenclature treats her4.1 and her4.3 as 







2.2 Drug administration 
2.2.1 Intraperitoneal injections  
Fish were anaesthetised by immersion in 0.02% MS222 in PBS and placed on a 
cooled surface. Using a 30 ½ G needle 25 µl was injected into the peritoneum on the 
left side. 4-hydroxytamoxifen (4OHT) was injected at a concentration of 0.5 mg/ml 
dissolved in dH2O. EdU was injected at a concentration of 4.11 mg/ml dissolved in 0.3 
x Danieau’s solution with 15% DMSO. Haloperidol was injected at a concentration of 
80 μg/ml dissolved in PBS. Haloperidol decanoate was injected at a concentration of 
20 mg/kg. Metronidazole was injected at a concentration of 5mg/ml dissolved in PBS. 
MPTP was injected at concentrations of 2 mg/ml and 3 mg/ml dissolved in PBS. Sham 
injected animals were injected with vehicle solutions. 
2.2.2 Cerebroventricular injections 
Fish were anaesthetised by immersion in in 0.02% MS222 in PBS and mounted in a 
wet sponge surrounded by ice water. A small hole was created in the skull directly 
above the left optic tectum using sharp forceps. A glass capillary needle was inserted 
into this hole at a 45° angle from the caudal edge of the tectum into the third ventricle. 
A pressure injector (IM-300 microinjector, Narishige International, Inc. USA) was used 
to inject 0.5 to 1.0 µL of solution containing 0.12% fluorescent dextran-conjugate, thus 
distribution of the solution throughout the ventricular system could be verified under a 
fluorescence-equipped stereo-microscope. 6-hydroxydopamine hydrobromide 
(6OHDA) was injected at a concentration of 10 mM dissolved in PBS. Leukotriene C4 
(LTC4) was injected at a concentration of 500 ng/ml in 0.45% ethanol in H2O. MPP+ 
was injected at concentrations ranging between 1 and 10 mM dissolved in PBS. 
Zymosan was injected at a concentration of 10 mg/ml dissolved in PBS. Sham 




2.2.3 Immersion  
Adult fish were transferred into tanks containing drug in 1 L system water. Fish were 
transferred into fresh drug/vehicle every other day. When photosensitive chemicals 
were used tanks were protected from light. 4-hydroxytamoxifen (4OHT) was used at 
a concentration of 1 µM solution of 4OHT in system water. Dexamethasone was used 
at a concentration of 15 mg/L in system water with 0.06% DMSO. Metronidazole was 
used at a concentration of 10 mM in system water with 0.1% DMSO. Pomalidomide 
was used at a concentration of 100 nM in system water with 0.1% DMSO). Control 
animals were immersed in vehicle solution. Larvae were immersed in 100 µM EdU in 
1% DMSO in conditioned water, covered in foil, and incubated at 28.5°C.  
2.3 Spinal cord injuries 
Adult spinal cord lesions were performed by Dr. Thomas Becker as described 
previously (Becker et al. 1997). Briefly, fish were anaesthetised by immersion in 
0.02% MS222 in PBS and placed on a cool surface. A longitudinal incision was made 
to expose the vertebral column, equidistant from the operculum and the dorsal fin, 
and the spinal cord was completely transected under visual control.  
Larval spinal cord lesions were performed as described previously (Ohnmacht et al. 
2016). Briefly, at 3 dpf larvae were anaesthetised by immersion in 0.02% MS222 and 
transferred onto 4% agarose at room temperature in a lateral position. A 30½ G 
needle was used to make a dorsal incision transecting the entire spinal cord at the 
level of the 15th myotome, whilst ensuring the notochord remained intact. Sham 







2.4.1 Perfusion and fixation of adult tissue 
Fish were terminally anaesthetised by immersion in 0.1% MS222 in PBS. A 30 ½ G 
needle was inserted into the heart and used to perfuse the fish with PBS followed by 
4% PFA. The fish were stored in 4% PFA at 4°C overnight. Brains and spinal cords 
were carefully extracted, washed briefly in PBS, and embedded in 4% agar in PBS. A 
vibrating blade microtome (Leica VT1200S) was used to cut 50 µm sections.  
2.4.2 EdU detection in larval zebrafish  
Larvae were fixed in 4% PFA at 4°C overnight. The following day they were washed 
three times in 0.1% PBSTx for 5 minutes each before being transferred into 100% 
methanol for 5 minutes. This was then replaced with fresh methanol and the larvae 
were kept at -20°C for at least 2 hours. The larvae were gradually rehydrated in 75% 
methanol/PBS, 50% methanol/PBS, and 25% methanol/PBS, followed by three five 
minutes washes in 0.1% PBSTx. The yolk and head of each larva was removed 
manually and larvae were incubated with 10 µg/ml proteinase K in 0.1% PBSTx at 
room temperature for 45 minutes. Larvae were placed in 4% PFA for 15 minutes at 
room temperature, washed three times in 0.1% PBSTx for five minutes each, and then 
incubated in 1% DMSO/0.5% PBSTx for 20 minutes at room temperature. After 
another wash with 0.1% PBSTx as much PBSTx was removed as possible and the 
larvae were transferred into freshly prepared Click-iTTM reaction mix (Invitrogen, 







Reaction component Per 100 µl Reaction Mix 
Reaction buffer (10X) 8.6 µl 
H2O 77.2 µl 
CuSO4 4 µl 
Alexa Fluor 647 0.2 µl 
Buffer additive (1X) 10 µl 
Total 100 µl 
 
Table 2. 1 EdU Click-iT Reaction Mix 
Larvae were protected from light and incubated for two hours at room temperature on 
a shaker before three five minute washes in 0.1% PBSTx. Immunohistochemistry was 
then performed as described below. 
2.4.3 EdU detection in adult zebrafish  
Floating sections of adult brains and spinal cords were washed twice in 0.5% PBSTx 
for five minutes. The sections were then incubated in freshly prepared Click-iTTM 
reaction mix (Invitrogen, C10340, Table 2. 1) at room temperature for three hours 
whilst protected from light on a gentle shaker. Sections were then washed three times 
with 0.3% PBSTx, for 10 minutes each, followed by a fifteen minute wash with 1 x 
PBS.  
When EdU labelling was combined with immunohistochemistry, sections were then 
transferred into blocking solution. For EdU detection only, sections were then 
transferred to 70% glycerol and mounted.  
2.4.4 Immunohistochemistry on adult sections 
Floating sections were washed in PBS followed by a 10 minute wash in 0.1% PBSTx 




0.1% PBSTx for 30 minutes at room temperature and incubated with primary antibody 
overnight at 4°C. Following 3 x 15 minute 0.1% PBStx washes at room temperature, 
sections were protected from light whilst incubated in secondary antibody at room 
temperature for 45 minutes. Sections were washed in 0.1% PBStx for 2 x 15 minutes, 
followed by a 1 x 15 minute wash with PBS. Sections were then transferred to 70% 
glycerol before being mounted onto Superfrost slides. Cover slips were sealed with 
nail varnish and slides were stored at 4°C until imaged.  
2.4.5 Tissue clearing of adult spinal cord 
For tissue clearing, the spinal cord was extracted and embedded in ice cold hydrogel 
Clarity Solution 1 (see buffers section for details). The tube containing the sample was 
protected from light and stored at 4ºC for 1-2 days to allow for diffusion of the hydrogel 
into the tissue. The oxygen in the tube was then replaced with nitrogen gas, and the 
tube was incubated at 37ºC for 3 hours. The tissue was then extracted from the 
hydrogel and washed with Clarity Solution 2 at 37ºC on a shaker. The solution was 
replaced with fresh Clarity Solution 2 daily for two weeks. The spinal cord was then 
mounted in 87% glycerol for imaging.      
2.5 Molecular Biology  
2.5.1 Quantitative RT-PCR 
Adult zebrafish were terminally anaesthetised by immersion in 0.1% MS222 in PBS. 
The brain was extracted and embedded into 4% agar and sectioned horizontally. A 
section of 200 μm at the location used for analysis of progenitor cells around the 
ventricle was collected. The RNeasy® Mini Kit (QIAGEN, 74106) was used to extract 
RNA following the kit’s instructions. Briefly, samples were dissolved in 350 μl RLT 
buffer and stored at -20°C if required. 350 μl 70% ethanol was added and the samples 




cDNA synthesis was performed using the iScript™ cDNA Synthesis Kit (Bio-Rad, 
1708891). For each sample, a reaction mix was prepared containing 4 μl 5X Reaction 
Mix + 1 μl Enzyme + 15 μl RNA template, for a total volume of 20 μl per sample. 
Samples were then transferred into a PCR machine (programme: 5 min at 25°C, 20 
min at 46°C, 1 min at 95°C). SsoAdvancedTM Universal SYBR® Green Supermix (Bio-
Rad, 172-5271) was used for the quantitative RT- PCR. Samples were prepared in 
96-well plates at a volume of 20 μl per well, and each sample was tested in duplicate. 
The following primers were used: 18S: FW: 5’- TCGCTAGTTGGCATCGTTTATG-3’, 
RV: 5’- CGGAGGTTCGAAGACGATCA-3’, tnf-α: FW: 5’-
TCACGCTCCATAAGACCCAG-3’, RV: 5’-GATGTGCAAAGACACCTGGC-3’, il-1β: 
FW: 5’-ATGGCGAACGTCATCCAAGA-3’, RV: 5’-GAGACCCGCTGATCTCCTTG-3’. 
2.5.2 Genotyping  
Adult pink1-/- and pink1+/+ fish were anaesthetised by immersion in 0.02% MS222 in 
PBS and a small fin clip was cut. The tissue was dissolved with 100 µl 5 mM NaOH 
at 95 ºC for 1 hour and vortexing. 10 µl 1M Tris (pH8) was added and the sample was 
centrifuged at 1000 rpm for 2 minutes. The area of interest of the pink1 gene was 
amplified by PCR (forward primer sequence: 5’-TAGGTGTCCATGGCAGTG-3’, 
reverse primer sequence: 5’-CTGGTAACTCCGACTCTC-3’, PCR programme: 30 
seconds at 94ºC, 40 seconds at 50ºC, 40 seconds at 72ºC, 35 cycles). The PCR 
product was run on an agarose gel and extracted from the gel using the QIAquick Gel 
Extraction Kit (QIAGEN, 28706X4). Purified PCR products were sent for sequencing 
at Source Bioscience Sequencing (forward primer sequence: 5’-






2.6 Image Acquisition and Analysis 
Fluorescent images were obtained using a Zeiss LSM 710 confocal microscope. 
Images were analysed using Fiji (Schindelin et al. 2012). Figures were prepared using 
Adobe Photoshop CS3 and Adobe Illustrator CS6.  
2.6.1 Cell counting 
Wholemount larvae or 50 µm sections were imaged as z stacks, and cell counts were 
performed manually by going through the stack and counting the number of cells in a 
stereological fashion. For adult spinal cords, the number of cells was counted in three 
randomly selected sections from up to 750 µm rostral to the lesion site and three 
randomly selected sections 750 µm caudal to the lesion site. These counts were then 
used to calculate the number of cells around the lesion site. The numbers of EdU+ 
ERGs at the ventricle were counted in three 50 µm horizontal sections and summed 
together to give the total number per fish. Within each round of experiments, each fish 
was normalised to the average value of the sham fish for that round.  
2.6.2 4C4 immunoreactivity 
To assess the level of 4C4 immunoreactivity maximum projections were created and 
analysed using Fiji. The ratio of immunolabelling compared to the background signal 
was calculated for each section by dividing the mean grey value of the area around 
the ventricle by the mean grey value of the tissue background. Percentage covered 
was obtained by converting maximum projection images into binary images and using 
the “measure” function in Fiji to find the percentage area covered.   
2.7 Statistics 
Animals were randomly assigned to experimental groups and all quantifications were 




of spinal cord sections was analysed the sections were selected at random by 
assigning each section a number and using a random number generator.  
Statistical analyses were performed using GraphPad Prism and SPSS. Quantitative 
data were tested for normality (Shapiro-Wilk test) and heteroscedasticity (Levene’s 
test) before selecting the appropriate statistical tests, which are described in figure 
legends. Variability of values is always given as the standard error of the mean (SEM), 
and n numbers on the graphs represent the number of animals used in the 
experiment.  Power analyses were performed using G*Power3 (Faul et al. 2007).   
2.8 Materials 
2.8.1 Buffers 
- Blocking buffer for wholemount immunohistochemistry 
 1 x PBS 
1% DMSO 
1% BSA 
1% normal donkey  serum 
0.7% Triton™X-100 
- Clarity Solution 1  
 10 ml Acrilamide; Bis-Acrilamide 30% 
 0.75g VA-044 thermal initiator 
 50 ml 8% PFA 




 30 ml dH₂O 
- Clarity Solution 2 
 8.68 g boric acid 
 20 g sodium dodecyl sulfate 
 400 ml dH₂O 
 Adjust to pH 8.5 with NaOH 
- Paraformaldehyde (PFA) solution 4% (for fixation) 
 16g paraformaldehyde 
 40 ml 10 x PBS 
 Complete with dH₂O up to 400ml 
- Phosphate buffered saline (PBS), 10X, pH 7.4 
160 g NaCl 
28.3 g Na2HPO4 
4 g KCl 
4.8 g KH2PO4 







2.8.2 Primary antibodies 





Mouse 1:1000 Millipore, MAB318 
α-GFP Chicken 1:1000 Abcam, ab13970 
α-RFP Rabbit 1:500 Invitrogen, R10367 
4C4 Mouse 1:50 HPC Cell Cultures, 
92092321 
 
2.8.3 Secondary antibodies 
Antibody Dilution Supplier 
Cy3 Donkey α-mouse 1:200 JacksonImmunoResearch,  
715-165-150 
Alexa 488 Donkey α-
chicken 
1:200 JacksonImmunoResearch,  
715-545-150 
Alexa 647 Donkey α-
mouse 
1:200 JacksonImmunoResearch,  
715-605-150 
Cy3 Donkey α-rabbit 1:200 JacksonImmunoResearch,  
711-165-152 
 
2.8.4 List of Materials 


















Bovine Serum Albumin 
(BSA) 
A3912 Sigma-Aldrich 
Collagenase C9891 Sigma-Aldrich 
Copper (II) Sulfate 451657 Sigma-Aldrich 




Ethanol E7023 Sigma-Aldrich 
Formamide 47670 Sigma-Aldrich 
Glycerol G5516 Sigma-Aldrich 
Haloperidol H1512 Sigma-Aldrich 
Haloperidol Decanoate H0100100 Sigma-Aldrich 
Histoacryl Tissue Seal 9381104 B. Braun 
Hydrochloric acid, HCl 320331 Sigma-Aldrich 
Isopropanol I9516 Sigma-Aldrich 
Leukotriene C4 20210 Cayman Chemical 
Lithium Chloride LX026 Sigma-Aldrich 




Methylene Blue 3470.0025 VWR  International 
Metronidazole M1547 Sigma-Aldrich 
MPP+ D048 Sigma-Aldrich 
MPTP M0896 Sigma-Aldrich 




Pomalidomide 19877 Cayman Chemicals 




Proteinase K 3115801 Roche 
RNAse Zap R2020 Sigma-Aldrich 




Superfrost coated glass 
slides 
48311-703 VWR  International 
Torula yeast tRNA R6625 Sigma-Aldrich 
Triton X-100 93426 Sigma-Aldrich 
Tween 20 P1379 Sigma-Aldrich 








Chapter Three: Investigating the Origin of New 
Th+ Neurons in the Adult Zebrafish Brain 
3.1 Introduction 
The identification of newly generated Th+ neurons in the adult zebrafish brain (Figure 
1.4, (Grandel et al. 2006; Skaggs et al. 2014)) raises the question of where these new 
neurons originate from. In this chapter I describe a heterogeneous population of 
neural progenitor cells around the diencephalic ventricle in the adult zebrafish brain. 
I demonstrate using genetic lineage tracing that Th+ neurons formed after 6OHDA 
injection can be derived from a specific subset of these cells.  
3.1.1 New neurons are generated throughout the adult zebrafish brain  
In contrast to the comparatively few neurogenic niches identified in the adult 
mammalian brain (Eriksson et al. 1998; Ming & Song 2011), proliferative zones in the 
adult zebrafish brain are found all along the rostral-caudal axis (Grandel et al. 2006). 
A combination of immunohistochemistry for proliferating cell nuclear antigen (PCNA) 
and BrdU shortly after injection have revealed the location of numerous proliferative 
zones (Zupanc et al. 2005; Grandel et al. 2006; Adolf et al. 2006). Longer post-
injection times with BrdU have demonstrated that BrdU-labelled cells can migrate 
away from the proliferative zones and go on to become neurons, as shown by co-
labelling with pan-neuronal marker HuC and markers of specific neuronal subtypes 
(Zupanc et al. 2005; Grandel et al. 2006; Adolf et al. 2006). Immunohistochemistry for 




indicating that they are able to integrate into the existing neuronal circuitry 
(Rothenaigner et al. 2011).  
3.1.2 Neural progenitor cells in the adult zebrafish brain  
In adult zebrafish (and other anamniotes) new neurons are derived from progenitor 
cells called ependymo-radial glial cells (ERGs) (Becker & Becker 2015). These cells 
have a distinctive morphology, with a soma which forms part of the ependyma and 
radial processes extending across the entire span of the brain to the pial surface (Berg 
et al. 2011; Dirian et al. 2014). Evidence from clonal analysis using viral vectors 
(Rothenaigner et al. 2011) and repeated imaging of labelled ERGs in the adult 
zebrafish telencephalon (Barbosa et al. 2015b; Dray et al. 2015) demonstrates that 
these cells are self-renewing and generate multiple neuronal subtypes, two seminal 
characteristics of neural stem cells.  
In addition, ERGs express sox2, a marker of neural stem cells (Ogai et al. 2014). 
ERGs can also be identified by their expression of genes such as glial fibrillary acidic 
protein (gfap), aquaporin 4, vimentin, s100β, brain lipid binding protein (BLBP), olig2, 
glutamine synthase, and her4 (Kroehne et al. 2011; Ganz et al. 2010; Jung et al. 2012; 
Chapouton et al. 2011). 
In this chapter I focus on three genes expressed by ERGs which have been shown to 
generate new neurons in the adult zebrafish CNS, namely gfap, olig2, and her4. Due 
to the absence of astrocyte-like cells in the zebrafish, expression of gfap in the CNS 
is restricted to ERGs, and gfap:GFP+ cells in the optic tectum have been shown to act 
as proliferative neural progenitor cells (Jung et al. 2012).  Oligodendrocyte lineage 
transcription factor 2 (olig2) is expressed by ERGs in the telencephalon of adult 
zebrafish (Adolf et al. 2006), as well as ERGs in the ventral spinal cord which have 




2008). Hairy-related gene 4 (her4) is expressed by ERGs in the telencephalon. These 
ERGs have been shown to increase neurogenesis after a stab lesion or excitotoxic 
injection (Kroehne et al. 2011; Skaggs et al. 2014), and her4+ ERGs are the source 
of a diverse range of neuronal subtypes (Skaggs et al. 2014). Similarly, in the injured 
retina her4+ progenitor cells produce a variety of different neuronal subtypes, including 
amacrine, bipolar, and horizontal cells, as well as Müller glia (Wilson et al. 2016).  
3.1.3 Investigating where new Th+ neurons originate from in the adult 
zebrafish brain 
Given the high number and widespread locations of Th+ populations (Figure 1.1) and 
neural progenitor cells ((Grandel et al. 2006)) in the adult zebrafish brain,  I decided 
to limit my search for ERGs producing new Th+ neurons to the population with the 
highest regenerative capacity, which is population 5/6 (Figure 1.3, Figure 1.4). 
Compared to other Th+ populations, population 5/6 has a high number of new Th+ 
cells, demonstrated by the number of Th+ cells that had incorporated EdU (Figure 1.4), 
and so there is a relatively high chance of detecting new Th+ neurons in this population.  
  
3.1.4 Genetic Lineage Tracing 
There are several different approaches used to determine which population of cells 
gives rise to another population. Parent populations can be labelled by injecting dyes, 
electroporating plasmids encoding fluorescent reporters, or by genetic means.  
Here I have adopted a commonly used technique for genetic lineage tracing using the 
Cre-loxP system. Cre recombinase is expressed under the control of a cell type-
specific promoter to target its expression to a specific cell type. Separately, transgenic 
animals are generated containing a cassette with loxP target sequences flanking a 
fluorescent reporter, STOP sequence, or other marker. When animals are crossed 




loxP sites, removing the flanked gene from the cell’s genome. This system has been 
adapted to allow for temporal control. A modified Cre recombinase is fused to the 
human oestrogen receptor ERT2 (Feil et al. 1997). In the absence of tamoxifen or its 
active metabolite 4-hydroxytamoxifen (4OHT) the Cre resides in the cytoplasm of the 
cell, tethered to heat shock proteins, and insensitive to the endogenous ligand 17β-
oestradiol (Indra et al. 1999). Upon application of a ligand, the enzyme undergoes a 
conformational change allowing it be released from heat shock proteins and 
translocate to the nucleus when it becomes activated and enters the nucleus where it 
can induce recombination.  
The Cre/loxP method has been successfully used to trace the lineage of cells in the 
adult zebrafish, including those in the retina (Ramachandran et al. 2010), cornea (Pan 
et al. 2013), and the telencephalon (Kroehne et al. 2011; Skaggs et al. 2014).  
3.1.4.1 Genetic lineage tracing of her4+ ERGs using Tg(her4:CreERT2;β-
actin:loxP-mCherry-loxP-EGFP) zebrafish  
Genetic lineage tracing of her4+ cells is possible using existing models using the 
Cre/loxP system. The 3.4kb promoter of her4 (Yeo et al. 2007) has been used to drive 
the tamoxifen-inducible CreERT2 (Boniface et al. 2009). A separate transgenic line 
exists where the ubiquitously expressed β-actin2 promoter drives expression of the 
fluorescent reporter mCherry (Ramachandran et al. 2010), and so every cell is 
mCherry+ in the absence of tamoxifen. The mCherry sequence is flanked by two loxP 
sites and followed by an out of frame EGFP sequence. Upon activation, CreERT2 
translocates to the nucleus and specifically recognises the loxP sites, excising 
mCherry from the genome and bringing the GFP sequence into frame. This means 
cells which are her4+ at the time of 4OHT application, and all of their progeny, become 
permanently labelled with GFP (Figure 3. 1). These two transgenic lines have been 




identify new cells which have been derived from her4+ ERGs since the application of 
4OHT(Skaggs et al. 2014).  
 
Figure 3. 1 A schematic illustrating the two transgenes in Tg(her4:CreERT2;β-actin:loxP-
mCherry-loxP-EGFP) zebrafish. Upon activation with 4OHT, CreERT2 translocates to the nucleus 
and cuts at loxP sites, excising mCherry from the genome and bringing the EGFP into frame, thus 
permanently labels her4+ cells and their progeny.  
3.2 Results 
3.2.1 Cells lining the ventricle are a heterogeneous population of ERGs 
I used horizontal brain sections of fish with fluorescent reporters driven by three 
known markers of ERGs to observe the cells lining the diencephalic ventricle. 
gfap:GFP+ cells, olig2:DsRed+, and her4:mCherry+ cells are located at the 
diencephalic ventricle (Figure 3. 2), and exhibit the typical ERG morphology, with their 







Figure 3. 2 Cells lining the diencephalic ventricle express markers of ERGs and have the typical 
morphology of ERGs. A: The horizontal plane of sectioning for B and C is marked by the dotted 
line; rostral is left for all panels. B and C: Maximum projections showing the overlapping but 
different location of gfap:GFP+, her4:mCherry+, and olig2:DsRed+ ERGs around the diencephalic 
ventricle, white brackets indicate the approximate location of Th+ cells in population 5/6. Scale 
bars in B and C = 100µm. A and B are adapted from (Caldwell and Davies et al. 2018). 
Olig2:DsRed+ cells can be seen in the parenchyma, and these oligodendrocytes can 
be distinguished from ERGs by their location and cellular morphology. gfap:GFP+ and 
her4:mCherry+ cells were only found lining the ventricle, and all displayed the typical 




I observed overlapping but different expression patterns of gfap:GFP+, olig2:DsRed+, 
and her4:mCherry+ cells at the ventricle. In gfap:GFP;her4:mCherry double 
transgenic fish all her4:mCherry+ cells were also gfap:GFP+, but not all gfap:GFP+ 
cells were her4:mCherry+. In gfap:GFP/olig2:DsRed fish cells were gfap:GFP+ only, 
olig2:DsRed+ only, or gfap:GFP+/olig2:DsRed+. This shows for the first time that there 
is heterogeneity among these ERGs lining this ventricle. 
3.2.2 Regenerated Th+ cells are derived from her4+ ERGs 
To specifically induce recombination in her4+ ERGs I immersed adult 
Tg(her4:CreERT2; β-actin:LCLG) zebrafish in 4OHT for six days. Fish were injected 
with 6OHDA on the final day of 4OHT treatment and analysis was performed at 42 
dpi. This successfully induced recombination, demonstrated by the presence of GFP+ 
cells only in 4OHT treated fish (Figure 3. 3). However, I observed different densities 
of GFP+ cells, indicating variable recombination efficiency among 4OHT-treated fish. 
The majority of GFP+ cells were ERGs, as indicated by their position lining the 
ventricle and their distinctive radial morphology. Some GFP+ cells were also observed 
slightly removed from the ventricle, including double-labelled Th+/GFP+ cells (Figure 
3. 3). These Th+/GFP+ cells were always observed in proximity to GFP+ ERGs lining 
the ventricle, strongly suggesting that these Th+ cells are derived from ERGs at the 
diencephalic ventricle after 6OHDA injection. The number of Th+/GFP+ cells 









Figure 3. 3 New Th+ cells in the region of the 5/6 population formed after 6OHDA ablation are 
derived from her4+ ERGs. A: The horizontal plane of sectioning for B, D, and E is marked by the 
dotted line. B: ERGs are labelled in gfap:gfp transgenic fish with their somas at the ventricle and 
their radial processes alongside Th+ neurons. C: The experimental timeline. D: Maximum 
projections of horizontal sections (left rostral), white brackets indicate the approximate location 
of Th+ cells in population 5/6. The number of Th+/GFP+ cells correlates with the observed 
recombination efficiency. C: High magnification images of double labelled Th+/GFP+ cells, with 
orthogonal views. Scale bar in B = 25 µm, in D = 100 µm, in E = 10 µm. Figure is adapted from 









3.3.1 The cells lining the diencephalic ventricle in adult zebrafish are a 
heterogeneous population of ERGs 
Previous descriptions of ependymoradial glial cells in the adult zebrafish brain are 
largely limited to coronal sections through the brain. Differential expression patterns 
of genes known to be expressed by ERGs have been reported in the telencephalon 
(Ganz et al. 2010; Chapouton et al. 2011), the midbrain (Chapouton et al. 2011), and 
the hypothalamus (Chapouton et al. 2011). However, the diencephalic ventricle 
extends along the rostral-caudal axis, and this shape has hindered a clear description 
of the ERGs lining this ventricle in coronal sections. The results presented here 
provide the first description of the heterogeneity of ERGs around the diencephalic 
ventricle in the adult zebrafish brain, shown in horizontal sections (Figure 3. 2). 
3.3.2 Mapping the expression patterns of genes expressed by ERGs could 
help identify a Th+ neuron progenitor domain in the adult zebrafish 
brain 
Analysing the expression of different genes in ERGs can identify pools of 
progenitor cells programmed to make specific neuronal subtypes. For instance, 
in the zebrafish spinal cord the expression patterns of various transcription factors 
have been used to define groups of ERGs which all give rise to a specific neuronal 
subtype during development (Satou et al. 2012). At least some of these 
expression patterns persist into adulthood. For example, a motor neuron 
progenitor domain (pMN), defined by expression of olig2, is the source of new 
motor neurons generated both during development and in the regenerating adult 




The different but overlapping locations of gfap:GFP+, olig2:DsRed+, and 
her4:mCherry+ ERGs I have described (Figure 3. 2) suggest there may be similar 
progenitor domains around the diencephalic ventricle. Future experiments could 
focus on mapping the expression of additional transcription factors expressed by 
ERGs, particularly those involved in Th+ neurogenesis during development, such 
as otpa, otpb, nr4a2a, nr4a2b, lmx1a, lmx1b.1, pitx3, and olig2 (Andersson et al. 
2006; Filippi et al. 2007; Tay et al. 2011b; Chen et al. 2013; Mahler et al. 2010) . 
This could lead to the identification of a specific pool of ERGs responsible for 
making new Th+ neurons in the adult brain, similar to the pMN domain described in 
the spinal cord.  
Additionally, genetic lineage tracing with other markers of progenitor cells could 
elucidate the range of ERGs capable of making Th+ neurons in the adult zebrafish 
brain. For example, olig2 has been shown to be involved in neurogenesis of Th+ 
neurons during development (Mahler et al. 2010), and here I have shown the 
presence of olig2:DsRed+ ERGs at the diencephalic ventricle in a similar location to 
new Th+ neurons (Figure 3. 2, The her4 promoter could be replaced with the olig2 
promoter to induce Cre expression in olig2+ cells, and this would establish whether 
ERGs which produce Th+ neurons are also olig2+. Repeating this with other markers 
of ERGs could develop an expression profile of ERGs which produce Th+ neurons in 
the adult zebrafish brain, identifying a Th+ neuron progenitor domain analogous to 
the pMN domain in the lesioned adult spinal cord.  
3.3.3 Th+ neurons are derived from her4+ ERGs at the diencephalic 
ventricle  
Here I have demonstrated that in the adult zebrafish brain Th+ neurons formed after 
6OHDA injection can be derived from her4+ ERGs at the diencephalic ventricle 




in the regenerating adult brain after either a stab lesion to the telencephalon 
(Kroehne et al. 2011) or  injection of the excitotoxin quinolinic acid (Skaggs et al. 
2014) can be derived from her4+ ERGs.  
In the salamander, Th+ neurons formed after 6OHDA ablation are derived from gfap + 
ERGs, as demonstrated by lineage tracing using in vivo electroporation of a plasmid 
encoding YFP, which specifically labelled gfap+ ERGs (Berg et al. 2011). As I found 
all her4:mCherry+ cells around the diencephalic ventricle are also gfap:GFP+, this 
suggests that regenerated Th+ neurons may be derived from ERGs expressing similar 
markers across species.  
The images of GFP+/Th+ cells (Figure 3. 3) show that some of the lineage-traced 
neurons are catecholaminergic, and in the same location as the dopaminergic 5/6 
population. However, the labelled ERGs may not produce Th+ neurons exclusively, 
as GABAergic and calretinin+ neurons have also been described among the progeny 
of her4+ ERGs in the telencephalon (Skaggs et al. 2014). Similarly, her4+ progenitor 
cells in the retina are the source of a wide range of different retinal cells (Wilson et al. 
2016), demonstrating that her4+ ERGs are capable of generating multiple neuronal 
subtypes in the adult zebrafish.    
On the other hand, some Th+ neurons formed after ablation may originate from her4- 
ERGs. If the recombination efficiency could be improved, perhaps by immersing fish 
in 4OHT for a longer time period, then future experiments combining genetic lineage 
tracing with EdU labelling could help to answer this question. If all her4+ cells and their 
progeny are labelled with GFP before fish are injected with EdU, then any 





3.3.4 Future experiments could investigate the cellular dynamics of ERGs 
at the diencephalic ventricle in the adult zebrafish brain 
Following several iterations of a protocol for the administration of 4OHT, I obtained 
optimal recombination efficiency by immersing fish in 4OHT for six days, as illustrated 
in the experimental timeline (Figure 3. 3B). However, even with this prolonged 
exposure to 4OHT the recombination efficiency observed varied between fish (Figure 
3. 3). This limits the potential for quantitative analyses, for example comparing the 
number of new Th+ cells generated in 6OHDA injected fish with sham injected fish.  
On the other hand, a lower recombination efficiency of cells lining the diencephalic 
ventricle could be advantageous for tracking the behaviour of individual ERGs. In the 
telencephalon, ERGs are located on the outer surface of the brain, and are therefore 
accessible for live imaging even in adult zebrafish (Dray et al. 2015; Barbosa et al. 
2015b). Repetitive imaging of individual ERGs has provided insight into the cellular 
dynamics underlying self-renewal and neurogenesis, including the identification of 
neurons formed through the direct conversion of ERGs into neurons, seemingly 
without proliferation, as well as neurons formed as a result of symmetric and 
asymmetric cell divisions.  
Techniques such as multiphoton microscopy allow for live imaging up to depths of 
~2000 µm, which would include a dorsal view of ERGs at the diencephalic ventricle. 
Therefore, in the future, genetic lineage tracing as described here could be combined 
with fluorescent reporters of dopaminergic neurons to investigate the cellular 
dynamics of ERGs at the diencephalic ventricle, and establish which of the methods 
of neurogenesis described in the telencephalon apply to dopaminergic neurons 






Cells lining the ventricle display the morphology of ERGs, and express typical markers 
of progenitor cells gfap, olig2, and her4. There is heterogeneity in the combinations 
of markers these cells express, and this appears to correlate with the spatial location 
of the cells around the ventricle. Using genetic lineage tracing, I showed that Th+ 





Chapter Four: Investigating the Signalling 
Pathways Involved in the Regeneration of Th+ 
Neurons 
4.1 Introduction 
Neurogenesis of Th+ neurons is increased following ablation with 6OHDA, as 
demonstrated by an increase in the number of Th+/EdU+ cells in population 5/6 (Figure 
1.4). In the previous chapter I showed that after ablation, new Th+ neurons originate 
from ERGs at the diencephalic ventricle (Figure 3. 3).  
Here I investigate the signals involved in the increased Th+ neurogenesis after 
ablation of Th+ neurons. A number of different signalling mechanisms have been 
shown to mediate neuroregeneration, including the re-deployment of developmental 
signalling pathways, as well as regeneration specific mechanisms (Becker & Becker 
2015; Kizil et al. 2012; Kyritsis et al. 2012; Berg et al. 2011). First I investigate the role 
of the immune system, which has been implicated in a wide range of regenerative 
processes across species. I assess the effect of immune activation and immune 
suppression on ERG proliferation and Th+ neurogenesis, as well as the effects of 
modulating specific immune molecules.  Secondly, I ask whether ERGs proliferate in 
response to the reduced levels of dopamine in the brain after a loss of Th+ neurons 
(Figure 1.2).  
4.1.1 The immune system and regeneration 
In the CNS the main mediators of inflammation are resident immune cells called 
microglia. A significant degree of neuronal cell death in the CNS is likely to elicit an 
immune response, whether the damage is caused by a mechanical lesion, chemical 




chronic neurodegenerative diseases, such as Alzheimer’s disease (Clayton et al. 
2017), Parkinson’s disease (Joshi & Singh 2018), and Multiple Sclerosis (Herranz et 
al. 2016). Similarly, traumatic brain injuries, strokes, and spinal cord injuries elicit a 
significant immune response (Lehnardt 2009).  
The effect of this immune reaction on the process of regeneration appears to be 
multifaceted, and the overall influence of an immune reaction on the extent and speed 
of repair varies depending on the timing and magnitude of the immune reaction, the 
type of insult, the area of the CNS affected, and the species being investigated 
(DiSabato et al. 2016). Immune cells can perform positive functions such as clearing 
dying cells and debris, abating infection, and even producing pro-regenerative 
molecules (Kyritsis et al. 2012; Bhattarai et al. 2016). If delivered with the appropriate 
timing and measure, promoting an immune response has been shown to accelerate 
regeneration (Tsarouchas et al. 2018). 
4.1.1.1 The immune system and neuroregeneration of the CNS in zebrafish  
Successful neuroregeneration in zebrafish has been studied using a variety of 
different models. Regardless of the method used to damage the CNS, a response is 
elicited from the resident immune cells of the CNS, microglia, whether neurons are 
lost due to a mechanical lesion (Becker & Becker 2001; Kyritsis et al. 2012; Ohnmacht 
et al. 2016), a (chemo)genetic manipulation (Flinn et al. 2013; Ohnmacht et al. 2016), 
or injection of a neurotoxic substance (Skaggs et al. 2014; Bhattarai et al. 2016). This 
correlation between eliciting an immune response and successful regeneration of the 
CNS has inspired investigations into whether an immune response is necessary 
and/or sufficient to induce neurogenesis, primarily through pharmacological 




In zebrafish larvae, a spinal cord lesion elicits a response from immune cells, including 
microglia (Ohnmacht et al. 2016; Tsarouchas et al. 2018). Suppression of the lesion-
induced immune response with the synthetic glucocorticoid dexamethasone impairs 
spinal cord regeneration after a lesion, demonstrated by a reduction in neurogenesis 
of motor neurons (Ohnmacht and Yang et al. 2016) and inhibition of the regeneration 
of axons crossing the lesion site (Tsarouchas et al. 2018). Conversely, treating 
lesioned larvae with the immuno-stimulant lipopolysaccharide (LPS) improved axonal 
regeneration at 24 hours post lesion (Tsarouchas et al. 2018).     
Similarly, a stab lesion to the adult telencephalon also leads to the recruitment of 
microglia/macrophages to the lesion site (Kyritsis et al. 2012). Inhibition of this 
immune response with dexamethasone treatment reduced the number of proliferating 
ERGs and the number of newly formed neurons after an injury, indicating that an 
immune response is necessary for successful neuroregeneration in least some areas 
of the adult zebrafish brain. Moreover, stimulating an immune response in the 
absence of a mechanical lesion was shown to be sufficient to increase the 
neurogenesis. However, the authors did not show any results demonstrating the effect 
of stimulating the immune system after a physical lesion, in other words, whether 
immune activation could boost regeneration. 
These findings suggest that a response from microglia is required for the successful 
replacement of neurons after injury of the CNS, and that stimulating the immune 
system alone can promote neurogenesis in the adult brain. However, the results 
discussed here are limited to models with physical injury, where a microglial reaction 
is likely to be more pronounced than other CNS insults due to greater tissue disruption 
and hence more debris to be cleared. This led us to ask whether the immune system 
plays a similar role in neuroregeneration when a specific population of neurons is 




4.1.1.2 Molecular mechanisms for the interaction between the immune system 
and neuroregeneration 
The discovery of a key role for the immune system in regeneration inspired 
investigations into molecular signals which may be released from microglia to instruct 
ERGs to proliferate and increase neurogenesis. In this chapter I have focussed on 
two molecules which are released by immune cells and have been shown to promote 
regeneration of the zebrafish CNS.  
Leukotrienes are peptide-conjugated lipids and act as pro-inflammatory mediators 
synthesised and released by microglia in response to stimulation. Expression of the 
leukotriene receptor gene cysteinyl leukotriene receptor 1 (cysltr1) is increased 
around the ventricle in the lesioned hemisphere after a stab lesion in the adult 
zebrafish telencephalon, and also when microglia are activated with zymosan in the 
absence of an injury (Kyritsis et al. 2012). Both a stab lesion and zymosan injection 
lead to increased proliferation of ERGs, indicating that leukotrienes could be released 
by activated microglia and increase ERG proliferation.  
Injection of leukotriene C4 (LTC4), one of the ligands for cysltr1, increased 
proliferation of ERGs and increased neurogenesis in the uninjured telencephalon 
(Kyritsis et al. 2012). On the other hand, the cysltr1 antagonist pranlukast decreased 
radial glial cell proliferation and neurogenesis in the lesioned telencephalon. This 
suggests that cysltr1 signalling is both necessary and sufficient for neurogenesis in 
the adult telencephalon. However, whether this applies to ERGs in other brain areas, 
such as the diencephalon, and to neurogenesis of dopaminergic neurons, is not 
known.  
The immune response which occurs alongside regeneration of the zebrafish CNS 




tnf-α and il-1β are increased after a stab lesion to the telencephalon (Kyritsis et al. 
2012) and a spinal cord lesion in larvae (Tsarouchas et al. 2018). Inhibiting tnf-α 
signalling, either pharmacologically with pomalidomide or with CRISPR/Cas9 targeted 
to tnf-α, impaired regeneration of the spinal cord in larval zebrafish (Tsarouchas et al. 
2018). This demonstrates that tnf-α signalling is necessary for successful 
neuroregeneration in the zebrafish CNS, but the role of tnf-α in promoting 
neurogenesis in the adult zebrafish brain is not yet known.  
4.1.2 Dopamine as a molecule regulating the neurogenesis of Th+ neurons 
The signalling pathways underlying the replacement of neurons in the zebrafish brain 
have been investigated using models where a general insult is used to induce 
neuronal cell death, such as mechanical lesions, excitotoxic injury, or injection of  cell-
penetrating Aβ42 derivatives (Kyritsis et al. 2012; Skaggs et al. 2014; Bhattarai et al. 
2016). As cell death is not specifically induced in one particular type of neuron, 
neurogenesis is measured by counting the numbers of new cells co-labelled with pan 
neuronal markers such as HuC (Kyritsis et al. 2012; Skaggs et al. 2014; Bhattarai et 
al. 2016). In contrast, the advantage of our 6OHDA model is that I can investigate the 
signals involved in specifically replacing one neuronal cell type. It is conceivable that 
after a selective loss of dopaminergic neurons there may be a specific signalling 
mechanism in place to sense this loss and instruct neural progenitor cells to generate 
new dopaminergic neurons, rather than a general signal to increase neurogenesis. 
In the salamander, Th+ neurons can be ablated by 6OHDA injection, demonstrated 
by a 75% reduction in the number of Th+ cells of and the presence of TUNEL+/Th+ 
cells only in 6OHDA-injected animals (Parish et al. 2007). The number of Th+ cells is 
recovered by 30 days post 6OHDA injection (Parish et al. 2007). Th+ cell numbers are 
restored through the recruitment of quiescent progenitor cells, as demonstrated by 




Th+/BrdU+ cells in sham injected controls (Parish et al. 2007). Lineage tracing by 
electroporating plasmids encoding fluorescent proteins into ventricular cells revealed 
that gfap+ ERGs cells give rise to new Th+ neurons after 6OHDA injection (Berg et al. 
2010). Interestingly, the number of proliferating ERGs was dramatically reduced by 
injection of the dopamine precursor L-DOPA in 6OHDA-injected animals, but not in 
sham-injected controls, or when cholinergic neurons were ablated instead (Berg et al. 
2011). Furthermore, L-DOPA inhibited the recovery of Th+ neurons after 6OHDA 
ablation, indicating that an increased level of dopamine in the brain can inhibit 
regeneration of Th+ neurons. On the other hand, the dopamine receptor antagonist 
haloperidol evoked ERG proliferation and Th+ cell numbers, showing that mimicking 
the decreased levels of dopamine seen after ablation of Th+ neurons (Figure 1.2, 
Thiele et al. 2012; Hoffman et al. 1997) can induce Th+ neurogenesis. Both D1 and 
D2 dopamine receptors were found to be expressed by ERGs in the midbrain, but a 
selective D1 receptor antagonist had no effect on cell cycle re-entry, suggesting the 
signalling is mediated through D2 receptors. Taken together, these results suggest 
that the level of dopamine regulates the proliferation of ERGs, thus driving the 
regeneration of Th+ neurons after 6OHDA-induced ablation. 
Neurotransmitters, including dopamine, have been shown to influence proliferation of 
ERGs in the zebrafish spinal cord (Reimer et al. 2013; Barreiro-Iglesias et al. 2015). 
Dopamine regulates neurogenesis during development (Reimer et al. 2013; 
Ohnmacht et al. 2016), and dopamine signalling after a spinal cord lesion is required 
and sufficient to induce neurogenesis of motor neurons in adult zebrafish (Reimer et 
al. 2013).  This demonstrates that ERGs in at least some parts of the CNS of adult 
zebrafish are responsive to dopamine, and that dopamine can affect neurogenesis. 
However, the effect of dopamine signalling on the neurogenesis of Th+ neurons in the 





4.2.1 Injection of 6OHDA elicits an immune response  
Injection of 6OHDA leads to dopaminergic cell death in population 5/6, as shown by 
the presence of TUNEL+/dat:GFP+ cells in 6OHDA injected fish only (Figure 4. 1). At 
the location of population 5/6, microglia appear more abundant in 6OHDA injected 
brains compared to sham controls, and in some cases appear to engulf 
TUNEL+/dat:GFP+ cells, indicating activation of these immune cells.  
 
 Figure 4. 1 6OHDA elicits an immune response. A: Sagittal sections of population 5/6 in dat:GFP 
fish, showing increased TUNEL and microglia labelling. B: High magnification images with 
orthogonal views show a GFP+/TUNEL+ neuron engulfed by a microglial cell. Scale bar in A = 50 
μm, B = 5 μm. A was performed and imaged by Nick Davies, images in B were taken by myself. 
Figure is adapted from (Caldwell & Davies et al. 2018). 
Together with Leonardo Cavone, a postdoctoral researcher in our group, I assessed 
the levels of pro-inflammatory cytokines after 6OHDA injection. Fish were injected 
with 6OHDA and RNA was extracted from a horizontal brain section comprising 




showed a 6OHDA-induced increase in expression of the pro-inflammatory cytokines 
tnf-α and il-1β compared to sham injected fish (Figure 4. 2, fold increase in tnf-α 
expression: 5.788 ± 1.398 compared to sham: 1.00 ± 0.00, fold increase in il-1β 
expression: 2.199 ± 0.4399 compared to sham: 1.00 ± 0.00), confirming that there is 
an immune response to 6OHDA injection. This increase was abolished by immersing 
the fish in the immunosuppressant dexamethasone (Figure 4. 2, fold increase in tnf-α 
expression: 0.9325 ± 0.3086 compared to sham: 1.00 ± 0.00, fold increase in il-1β 
expression: 0.7868 ± 0.5214 compared to sham: 1.00 ± 0.00). This shows that 
dexamethasone treatment can reduce the immune response to levels comparable 
with sham injected fish, and allowed us to investigate whether the 6OHDA-induced 






Figure 4. 2 6OHDA increases expression of pro-inflammatory cytokines. A: The level of horizontal 
section used for analysis is shown. B: The experimental timeline is given. C: Quantitative RT-
PCR shows that expression of il-1β and tnf-α is increased compared to sham injected controls 
(1, indicated by the red line), but not in fish also treated with dexamethasone. One-tailed one-
sample t-tests (*p < 0.05). N numbers on the graphs indicate the number of fish used in each 
condition. Figure is adapted from (Caldwell & Davies et al. 2018). 
 
4.2.2 6OHDA increases proliferation of ERGs, and an immune response is 
necessary for this increase in progenitor proliferation 
As discussed in the previous chapter, in the adult zebrafish brain Th+ cells are derived 
from ERGs lining the diencephalic ventricle (Figure 3. 3), and these cells are a 
heterogeneous population in terms of expression of gfap and olig2 (Figure 3. 2), with 
subpopulations of gfap:GFP+/olig2:DsRed- cells, olig2:DsRed+/gfap:GFP- cells, and 
gfap:GFP+/olig2:DsRed+ cells. I could therefore investigate the effects of injecting 
6OHDA and modulating the immune response on the proliferation of these progenitor 





Figure 4. 3 6OHDA injection increases ERG proliferation, which is abolished by dexamethasone 
treatment. A: The section level of photomicrographs (A, rostral is left). B: The experimental 
timeline is given. C,D: Overviews (C) of the quantification areas and higher magnifications of 
ventricular cells (D) are given. EdU-labelled ERGs are gfap:GFP+, olig2:DsRed+, or both. White 
brackets indicate the approximate location of Th+ cells in population 5/6. E-G: Quantification of 
the normalised numbers of EdU+ ERGs in each treatment co-labelled with only gfap:GFP (E), only 
olig2:DsRed (F) or both gfap:GFP and olig2:DsRed (G). One-way ANOVA with Bonferroni post-
hoc test, *p < 0.05, **p < 0.01, ***p<0.001. Scale bars in C = 100 μm; in D = 10 μm. Figure is adapted 
from (Caldwell & Davies et al.2018). 
Injection of 6OHDA led to an increase in the number of gfap:GFP+/olig2:DsRed-EdU+ 




gfap:GFP-/olig2:DsRed+ (p=0.079) orgfap:GFP+/olig2:DsRed+ cells (p=1.000). 
However, the effect of 6OHDA on gfap:GFP-/olig2:DsRed+ cells was approaching 
significance, and so more animals could be used to determine whether there is a 
significant increase in this population of ERGs or not (Figure 4. 3E-G: 
EdU+/gfap:GFP+/olig2:DsRed- cells: sham: 1.000 ± 0.1190, sham + dex: 0.6147 ± 
0.0718, 6OHDA: 1.483 ± 0.1138, 6OHDA + dex: 0.8525 ± 0.1239; EdU+/gfap:GFP-
/olig2:DsRed+ cells: sham: 1.000 ± 0.1958, sham + dex: 1.120 ± 0.2847, 6OHDA: 
1.801 ± 0.3491, 6OHDA + dex: 0.9953 ± 0.2654; gfap:GFP+/olig2:DsRed+ cells: sham: 
1.000 ± 0.1170, sham + dex: 0.6397 ± 0.1088, 6OHDA: 1.098 ± 0.1464, 6OHDA + 
dex: 0.7113 ± 0.1003).  
To test whether an immune response affects the number of proliferating progenitor 
cells I incubated adult zebrafish in the immunosuppressant dexamethasone and 
counted the number of EdU+ cells expressing markers of ERGs. Immunosuppression 
did not affect the number of EdU+ progenitor cells after a sham injection; however, the 
6OHDA-induced increase in proliferation was abolished by immunosuppression 
(Figure 4. 3E-G: EdU+/gfap:GFP+/olig2:DsRed- cells: sham: 1.000 ± 0.1190, sham + 
dex: 0.6147 ± 0.0718, 6OHDA: 1.483 ± 0.1138, 6OHDA + dex: 0.8525 ± 0.1239; 
EdU+/gfap:GFP-/olig2:DsRed+ cells: sham: 1.000 ± 0.1958, sham + dex: 1.120 ± 
0.2847, 6OHDA: 1.801 ± 0.3491, 6OHDA + dex: 0.9953 ± 0.2654; 
gfap:GFP+/olig2:DsRed+ cells: sham: 1.000 ± 0.1170, sham + dex: 0.6397 ± 0.1088, 
6OHDA: 1.098 ± 0.1464, 6OHDA + dex: 0.7113 ± 0.1003). Hence, the immune 
response elicited by 6OHDA is necessary to increase the proliferation of ERGs.   
4.2.3 An immune response is necessary for efficient regeneration of Th+ 
neurons  
I hypothesised that immunosuppression may also impair regeneration of Th+ cells. 




with dexamethasone with vehicle-treated fish 42 days after 6OHDA injection. In 
population 5/6, the number of Th+ neurons generated after 6OHDA injection 
(Th+/EdU+ cells) was reduced by 58.8% in immunosuppressed fish compared to 
vehicle-treated controls (Figure 4. 4D, 6OHDA: 8.25 ± 1.708, 6OHDA + dex: 3.4 ± 
0.8944). I then tested whether suppressing the immune reaction caused by a 6OHDA 
injection would also lead to lower numbers of overall Th+ cells. I found lower numbers 
of Th+ neurons in the 5/6 population in fish treated with dexamethasone compared to 
controls, confirming that dexamethasone treatment impaired the replacement of Th+ 
neurons following ablation (Figure 4. 4E, 6OHDA: 270.0 ± 16.94, 6OHDA + dex: 201.4 





Figure 4. 4 Dexamethasone inhibits regeneration of Th+ neurons in the 5/6 population. A: The 
experimental timeline is given. B: In sagittal sections, EdU+/Th+ neurons can be observed (arrows) 
after 6OHDA injection, with or without addition of dexamethasone. C: High magnification and 
orthogonal views of an EdU+/Th+ neuron are shown. D,E: The number of EdU+/Th+ (D) and the 
overall number of Th+ neurons (E) are reduced by treating 6OHDA-injected animals with 
dexamethasone (Mann Whitney-U test, *p < 0.05 (D), Student’s t test, *p < 0.05 (E)). Scale bar in B 





4.2.4 Activating an immune response is sufficient to increase progenitor 
proliferation, but does not significantly enhance 6OHDA-induced ERG 
proliferation 
I hypothesised that a microglial response could be sufficient to increase proliferation 
of ERGs, leading to more efficient regeneration of Th+ neurons. Therefore, I decided 
to stimulate an immune response by injecting zymosan, a component of fungal cells 
walls used to induce sterile inflammation (Underhill 2003; Kyritsis et al. 2012). Nick 
Davies, a previous PhD student in our group, showed that injection of zymosan into 
the brain caused an immune response, demonstrated by the increase in microglia 
labelled with 4C4 (Caldwell and Davies et al. 2018). I injected zymosan into the brain 
and extracted RNA from a horizontal section containing population 5/6 and the 
diencephalic ventricle. Quantitative RT-PCR results for the pro-inflammatory 
cytokines tnf-α and il-1β were highly variable, but the average increase in mRNA for 
both cytokines was more than 40-fold compared to sham injected fish, which 
combined with the p values suggests that zymosan had an effect on the immune 
system (Figure 4. 5, fold increase compared to sham, tnf-α: 46.89 ± 24.63 compared 
to sham: 1.00 ± 0.00 (p=0.2035), il-1β: 49.06 ± 22.31 compared to sham: 1.00 ± 0.00 
(p=0.1641)). As the results of this experiment did not reach statistical significance and 
the variation of the result was so high, more animals could help determine whether 






Figure 4. 5 Zymosan increases expression of pro-inflammatory cytokines. A: The level of the 
horizontal section used for analysis is shown. B: The experimental timeline is given. C: 
Quantitative RT-PCR shows expression of il-1β and tnf-α is increased compared to sham injected 
controls (1, indicated by the red line). One-tailed one-sample t-tests (*p < 0.05). N numbers on the 
graphs indicate the number of fish used in each condition. 
 
Injections of zymosan alone were sufficient to increase the number of EdU+ progenitor 
cells for both gfap:GFP+/olig2:DsRed- (p=0.004) and gfap:GFP-/olig2:DsRed+ cells 
(p=0.20), indicating that inducing a microglial response is able to affect proliferation 
of ERGs (Figure 4. 6, EdU+/gfap:GFP+/olig2:DsRed-: sham: 1.000 ±  0.04478, sham 
+ zy: 1.583 ± 0.1695, 6OHDA: 1.560 ± 0.1506, 6OHDA + zy: 2.242 ± 0.2369, 
EdU+/gfap:GFP-/olig2:DsRed+: sham: 1.000 ± 0.05786, sham + zy: 1.609 ± 0.1344, 
6OHDA: 2.157 ± 0.2405, 6OHDA + zy: 2.232 ± 0.2402, 
EdU+/gfap:GFP+/olig2:DsRed+: sham: 1.000 ± 0.2655, sham + zy: 1.322 ± 0.3214, 





Figure 4. 6 6OHDA and zymosan both increase ERG proliferation. A: The level of the horizontal 
section used for analysis is shown, marked by the dotted line. B: The experimental timeline is 
given. C-F: 6OHDA injections and zymosan injections significantly increase proliferation of 
ventricular cells. White brackets in C indicate the approximate location of Th+ cells in population 
5/6. D,-F:  One-way ANOVA with Welch’s correction and Games-Howell post-hoc test (*p < 0.05, 
**p < 0.01, ***p < 0.001). Scale bar in C = 100 μm. Figure is adapted from (Caldwell & Davies et al. 
2018). 
However, zymosan injections did not affect the number of EdU+ ERGs cells after 
ablation when compared to 6OHDA alone, and this was the case for all of the 
subtypes of ERGs counted (Figure 4. 6). This suggests that although the proliferation 
of ERGs may be increased by both drugs alone, there may be a maximal limit to the 
proliferation capacity of ERGs which cannot be overcome by injecting both zymosan 





4.2.5 Activating an immune response is not sufficient to increase regeneration 
of Th+ neurons 
To determine whether enhancing the immune response could increase the 
regeneration of Th+ neurons I assessed the number of EdU+/Th+ cells after 6OHDA 
injection with and without zymosan. In line with unchanged ERG proliferation (Figure 
4. 6), there was no effect of zymosan on either the number of newly generated Th+ 
cells labelled with EdU (Figure 4. 7D, 6OHDA: 7.667 ± 0.8819, 6OHDA + zy: 7.000 ± 
1.080), or the overall number of Th+ cells in population 5/6 (Figure 4. 7E, 6OHDA: 
244.4 ± 19.03, 6OHDA + zy: 232.7 ± 21.02). This indicates that inducing a microglial 






Figure 4. 7 Zymosan treatment does not augment Th+ neuron replacement in population 5/6. A: 
The experimental timeline is indicated. B: In sagittal sections, EdU+/Th+ neurons can be observed 
(arrows) after 6OHDA injection, with or without addition of zymosan. C: High magnification and 
orthogonal views of an EdU+/Th+ neuron are shown. D,E: The number of EdU+/Th+ (D) and the 
overall number of Th+ neurons (E) are not increased by treating 6OHDA-injected animals with 
zymosan (Student’s t-tests, (*p < 0.05)). Scale bar in B = 100 µm; in C = 10 µm. Figure is 





4.2.6 Activity of the immune system is neither necessary nor sufficient for 
constitutive Th+ neurogenesis 
A zymosan-induced microglial response was sufficient to increase the number of 
EdU+ ERGs at the ventricle (Figure 4. 6), from which Th+ neurons are derived (Figure 
3. 3). I therefore hypothesised that manipulating the immune response may affect the 
number of Th+ neurons in the absence of ablation. To test this, I compared the 
numbers of Th+ cells and newly generated Th+ cells after immunosuppression with 
dexamethasone and after stimulation of immune cells with zymosan. Sham injected 
fish were injected with EdU at 5 dpi and 10 dpi, and analysed at 42 dpi. In one group 
the immune system was activated by injecting zymosan at 5 dpi and 10 dpi, in another 
the immune system was suppressed by immersing the fish in dexamethasone from 





Figure 4. 8 Immune system manipulations in sham animals do not influence addition of new Th+ 
cells. A: Timeline of experiments with either zymosan or dexamethasone treatment. B: In sagittal 
sections, EdU+/Th+ neurons (arrowheads) can be observed in all experimental conditions.  C: 
High magnification and orthogonal views of a double-labelled neuron are shown. D,E: No 
changes were observed in the number of newly generated Th+ neurons and the overall number 
of Th+ neurons after dexamethasone or zymosan treatment (One-way ANOVA with Bonferroni 
post-hoc test used in D and E, *p < 0.05). Scale bar in B = 100 µm, scale bar in C = 10 µm. Figure 
is reproduced from (Caldwell & Davies et al. 2018).  
Both the numbers of newly generated (Th+/EdU+) neurons (Figure 4. 8D, sham: 4.400 
± 0.9214, sham + zy: 3.333 ± 0.7149, sham + dex: 3.222 ± 0.7027) and overall Th+ 




sham: 301.1 ± 21.93, sham + zy: 308.8 ± 28.65, sham + dex: 290.8 ± 29.12). This 
suggests that activation of the immune system is neither necessary nor sufficient for 
new Th+ cells to be generated. Hence, the reduction in the number of new Th+ cells 
after dexamethasone treatment is specific to ablation-responsive neurogenesis, and 
it is not a result of dexamethasone directly inhibiting the constitutive neurogenesis of 
Th+ cells.   
4.2.7 Irf8-/- zebrafish do not have reduced microglia in the adult brain  
Dexamethasone is a widely used immunosuppressant; however, the treatment may 
have unintended effects outside the immune system, confounding the results. I 
therefore sought to prevent a microglial response using a genetic model to provide 
more evidence for a requirement of the immune system in regeneration. Together with 
Karolina Mysiak, I investigated whether irf8-/- zebrafish, which have been shown to 
have fewer microglia in larvae (Shiau et al. 2015), could be used to assess the effects 





Figure 4. 9 Adult Irf8-/- zebrafish have the same microglia and proliferating cells around the 
diencephalic ventricle as Irf8+/- fish. A: Horizontal sections around the ventricle show similar 4C4 
labelling. White brackets indicate the approximate location of Th+ cells in population 5/6. B: 
Quantification of the percentage of the scanned area covered with 4C4 labelling (Student’s t-test, 
(*p < 0.05)). C: The experimental timeline for D-E is shown. D: Horizontal sections with EdU+ cells 
around the ventricle, white brackets indicate the approximate location of Th+ cells in population 
5/6. E: Quantification of the numbers of EdU+ cells lining the ventricle (Mann Whitney test, (*p < 
0.05)). B and C were performed by myself, histology and imaging in D was done by Karolina 
Mysiak, counting by myself.  
First I investigated whether I could detect a difference in the numbers of microglia in 
the brains of adult irf8-/- zebrafish compared to irf8+/- zebrafish. Compared to 
heterozygous fish, irf8-/- zebrafish had similar 4C4 labelling (Figure 4. 9A, B), 
suggesting that the reduced numbers of microglia in these fish during development is 
not conserved to adulthood (irf8+/-: 8.438% ± 0.7256%, irf8-/-: 6.546% ± 0.8479%). 
Secondly, we investigated whether these fish had a difference in the number of 
proliferating cells around the diencephalic ventricle in response to 6OHDA ablation. 




at 14 dpi. We observed no difference in the number of EdU+ cells lining the ventricle 
in irf8-/- fish compared to irf8+/- fish, indicating that there is no difference in the number 
of proliferating progenitor cells (Figure 4. 9 C-E, irf8+/-: 200.5 ± 71.49, irf8-/-: 284.9 ± 
49.44). From these results we concluded that irf8-/- fish are not a suitable model to 
investigate the role of the immune system in regeneration of the adult zebrafish brain.   
4.2.8 Investigating the molecular signals between microglia and ERGs  
Injection of 6OHDA and zymosan both increase the number of proliferating ERGs 
(Figure 4. 3, Figure 4. 6), and this led us to ask which signals allow ERGs to respond 
to these manipulations. 
4.2.8.1 Leukotriene C4 
Both zymosan and 6OHDA elicit an immune response involving an increase in 
cytokine expression (Figure 4. 2, Figure 4. 5). ERGs in the adult zebrafish brain 
express receptors for at least some pro-inflammatory cytokines (Kyritsis et al. 2012; 
Bhattarai et al. 2016). We therefore hypothesised that microglia are influencing 
progenitor proliferation through the release of a cytokine(s) which signals to ERGs, 
promoting their proliferation. 
Leukotriene C4 (LTC4) has been shown to increase proliferation of ERGs and 
neurogenesis in the uninjured telencephalon of adult zebrafish (Kyritsis et al. 2012). 
Together with Karolina Mysiak, I tested whether injecting LTC4 could also increase 
ERG proliferation and neurogenesis of Th+ cells.  
To address whether injections of LTC4 elicit a microglial response I assessed the 
level of 4C4 labelling after three consecutive daily injections of LTC4. I observed no 
significant increase between uninjected and vehicle-injected brains, demonstrating 
that neither the injection procedure itself nor the vehicle caused a microglial 




LTC4: 1.621 ± 0.1695). However, LTC4 injected brains had significantly more 4C4 
labelling than vehicle-injected brains, indicating that LTC4 induces a microglial 
response.  
 
Figure 4. 10 Injection of LTC4 elicits a microglial response. A: The experimental timeline is shown. 
B: Horizontal sections showing 4C4 labelling around the ventricle (left, rostral). White brackets 
indicate the approximate location of Th+ cells in population 5/6. Red dotted lines indicate the area 
used for quantification of 4C4 immunohistochemistry around the ventricle (see Methods (Section 
2.6.2) for details of quantification). C: Quantification of the 4C4 labelling around the ventricle 
shows LTC4, but not vehicle injection, causes an increase in microglia around the ventricle (One-
way ANOVA, *p < 0.05, **p < 0.01). Scale bar in B = 100μm. Figure is adapted from (Caldwell & 
Davies et al. 2018).  
 
To test whether LTC4 is sufficient to increase proliferation of progenitor cells Karolina 
Mysiak counted the numbers of ERGs (labelled with gfap:GFP, olig2:DsRed, or both 
markers) at the ventricle which were co-labelled with Proliferating Cell Nuclear 
Antigen (PCNA). We found no difference between animals treated with LTC4 and 
vehicle treated controls (Figure 4. 11), indicating that LTC4 is sufficient to elicit a 







Figure 4. 11 Injection of LTC4 does not affect the number of proliferating ERGs. A: The 
experimental timeline is shown. B: Horizontal sections showing PCNA+ ERGs around the 
ventricle. White brackets indicate the approximate location of Th+ cells in population 5/6 . C: High 
magnification images of PCNA+/gfap:GFP+ ERGs and PCNA+/olig2:DsRed+ ERGs. D: 
Quantificstion showing PCNA labelling in ERGs is not increased by LTC4 (Mann Whitney U test, 
*p < 0.05). Scale bar in B = 100 μm, scale bar in C = 10 μm. Figure is adapted from (Caldwell & 
Davies et al. 2018).  
4.2.8.2 Pomalidomide 
The pro-inflammatory cytokine tnf-α is elevated in the brains of 6OHDA-injected fish 
in comparison to sham-injected fish (Figure 4. 2). We hypothesised that tnf-α could 
be one of the key signals linking the microglial response with increased proliferation 
of ERGs, and may therefore be required for efficient regeneration of Th+ neurons. To 
test this I used the tnf-α signalling inhibitor pomalidomide and observed its effect on 





Figure 4. 12 Pomalidomide treatment did not affect proliferation or Th+ neurogenesis. A: The 
experimental timeline is given. B: Horizontal sections showing EdU+ ERGs around the ventricle. 
White brackets indicate the approximate location of Th+ cells in the 5/6 population. C-E: 
Quantification of the number of EdU+ ERGs around the ventricle, Mann Whitney U tests, (*p < 
0.05).    
Fish were injected with 6OHDA to ablate Th+ neurons and immersed in pomalidomide 
to inhibit the 6OHDA-induced tnf-α signalling. There was no difference in the number 
of EdU+ ERGs after pomalidomide treatment compared to vehicle-treated controls, 
suggesting that inhibition of tnf-α signalling alone is not sufficient to reduce ERG 
proliferation (Figure 4. 12, EdU+/gfap:GFP+/olig2:DsRed-: 6OHDA: 47.20 ± 5.499, 
6OHDA + pomalidomide: 45.80 ± 4.363, EdU+/gfap:GFP-/olig2:DsRed+: 6OHDA: 
14.60 ± 4.142, 6OHDA + pomalidomide: 12.40 ± 4.020, 
EdU+/gfap:GFP+/olig2:DsRed+: 6OHDA: 28.60 ± 6.742, 6OHDA + pomalidomide: 
28.40 ± 3.400). Furthermore, there was no difference in the numbers of new Th+ cells 
(Figure 4. 13, 6OHDA: 5.500 ± 0.6455, 6OHDA + pomalidomide: 3.500 ± 1.500Figure 
4. 12) and in the total numbers of Th+ cells in the 5/6 population (Figure 4. 13, 6OHDA: 





Figure 4. 13  Pomalidomide treatment did not affect the number of new Th+ neurons or the total 
number of Th+ neurons. A: The experimental timeline is given. B: Sagittal sections of the 5/6 
population showing Th+/EdU+ cells. C: Quantification of the number of Th+/EdU+ cells, Student’s 
t-test, (p=0.2084). D: Quantification of the numbers of Th+ cells, Student’s t-test, (p=0.3991). Scale 
bar in B = 100 μm    
4.2.8.3 Haloperidol 
6OHDA-induced ablation of Th+ neurons reduces the level of dopamine in the brain 
(Figure 1.2). In the salamander, the number of dopaminergic neurons is regulated by 
the level of dopamine in the brain (Berg et al. 2011), and so this reduction in dopamine 
signalling triggers an increase in Th+ neurogenesis. I asked whether dopamine 
signalling could also affect ERG proliferation and the regeneration of Th+ neurons in 
the adult zebrafish brain. 
To test whether inhibition of dopamine signalling affects the proliferation of ERGs I 
injected the dopamine receptor antagonist haloperidol and counted the number of 






Figure 4. 14 Inhibition of dopamine signalling with the dopamine receptor antagonist haloperidol 
did not alter the number of EdU+ cells lining the ventricle. A: The experimental timeline is shown. 
B: Horizontal sections of EdU+ cells around the ventricle (left, rostral), white brackets indicate the 
approximate location of Th+ cells in the 5/6 population. C: Quantification of the number of EdU+ 
cells lining the ventricle shows no effect of haloperidol (Student’s t-test, *p < 0.05). Scale bar in 
B = 100 µm. Figure is adapted from (Caldwell & Davies et al. 2018). 
Compared to vehicle-injected controls, haloperidol did not affect the number of EdU+ 
cells at the ventricle (Figure 4.14, vehicle: 71.63 ± 5.580, haloperidol: 79.14 ± 
7.414). This suggests that inhibiting dopamine signalling may not affect the 
proliferation of ERGs at the diencephalic ventricle in the adult zebrafish brain.  
In the absence of ablation zymosan was sufficient to increase ERG proliferation 
(Figure 4. 6), but this did not lead to increased neurogenesis of Th+ cells (Figure 4. 
8). We hypothesised that this is because without a lack of Th+ cells there is no signal 
instructing the proliferating ERGs/neuroblasts to become Th+ cells. I therefore tested 
whether a combination of zymosan plus the dopamine receptor antagonist haloperidol 





Figure 4. 15 Inhibition of dopamine signalling with the dopamine receptor antagonist haloperidol 
did not alter the number of EdU+ cells in the ERG layer. A: The experimental timeline is shown. 
B: Sagittal sections of population 5/6 showing EdU+/Th+ neurons (arrows) after zymosan 
injection, with or without addition of haloperidol. C: Quantification of the number of EdU+/Th+ 
cells shows no effect of haloperidol (Student’s t-test, *p < 0.05). Scale bar in B = 100 µm, scale 
bar in D = 5 μm. 
Sham-injected fish were injected with zymosan into the brain and intraperitoneal 
injections of EdU and haloperidol at 5 dpi and 10 dpi, followed by analysis at 42 dpi. 
To reduce mortality caused by multiple daily injections a long lasting form of 
haloperidol, haloperidol decanoate, was used. However, the addition of haloperidol 
did not affect the number of new Th+ neurons (Figure 4. 15, zymosan: 7.500 ± 1.848, 
zymosan + haloperidol: 7.667 ± 0.8819) and nor was there an effect on the overall 
number of Th+ neurons in population 5/6 compared to zymosan injection alone (Figure 
4. 15, zymosan: 289.0 ± 35.78, zymosan + haloperidol: 305.3 ± 28.54). This indicates 






4.3.1 6OHDA elicits an immune response 
Here I demonstrated for the first time that 6OHDA-mediated ablation of Th+ neurons 
elicits an immune response in zebrafish (Figure 1, Figure 4. 2). The presence of 
microglia engulfing TUNEL+ dopaminergic neurons in 6OHDA-injected fish indicates 
that the immune response is likely an indirect effect of 6OHDA injection, caused by 
the death of Th+ neurons. Ablation of Th+ neurons by injecting 6OHDA has previously 
been shown to induce an immune response in other in vivo models (Theodore & 
Maragos 2015). For example, in the salamander 6OHDA-mediated ablation of Th+ 
neurons led to an increased number of microglia in the brain at 3 dpi which persists 
to at least 45 dpi (Kirkham et al. 2011). Furthermore, patients with Parkinson’s disease 
also have immune activation (McGeer et al. 1988; Joshi & Singh 2018), involving 
increased levels of cytokines including tnf-α and il-1β (Nagatsu et al. 2000). Together 
this suggests that dopaminergic cell death triggers the response from microglial cells. 
4.3.2 6OHDA injection is sufficient to increase proliferation of ERGs 
I demonstrated for the first time that 6OHDA injection increases proliferation of ERGs 
around the diencephalic ventricle in zebrafish (Figure 4. 3, Figure 4. 6), which is in 
line with the increased Th+ neurogenesis observed after 6OHDA (Figure 1.4). 
6OHDA-induced proliferation of ERGs has previously been reported in the 
salamander (Berg et al. 2011).  
In the previous chapter I showed that the gfap:GFP+ population of ERGs around the 
diencephalic ventricle contains her4+ ERGs (Figure 3. 2), and that these her4+ ERGs 
give rise to Th+ neurons after 6OHDA ablation (Figure 3. 3). In line with these results, 
here I demonstrate that gfap:GFP+ are among the ERGs which respond to 6OHDA 




4.3.3 The immune system is necessary for the regeneration of dopaminergic 
neurons 
Here I demonstrated for the first time that neuroregeneration in the zebrafish brain 
can be inhibited by preventing an immune response in the absence of a traumatic 
brain injury (Figure 4. 3, Figure 4. 4). 
Dexamethasone treatment abolished the 6OHDA-induced increase in ERG 
proliferation and Th+ neurogenesis, impairing the replacement of Th+ cells in 
population 5/6. This indicates that an immune response is necessary for the 
regeneration of Th+ neurons in population 5/6 of the adult zebrafish brain. In 
contrast to my results, in the salamander immunosuppression with 
dexamethasone treatment resulted in an increase in the number of Th+ neurons, 
suggesting that immunosuppression enhances regeneration after 6OHDA 
injection (Kirkham et al. 2011) . The results I have presented here are in 
agreement with evidence that dexamethasone treatment reduces stab lesion-
induced ERG proliferation and neurogenesis in the zebrafish telencephalon 
(Kyritsis et al. 2012). This suggests that there could be species-specific effects of 
immunosuppression on the regeneration of neurons in the brain, but that 
dexamethasone impairs regeneration in various regions of the zebrafish brain.  
Dexamethasone has a wide range of effects beyond immunosuppression, including 
direct effects on the proliferation of stem cells. In the larval zebrafish spinal cord, 
dexamethasone reduces neurogenesis of motor neurons after spinal cord injury 
(Ohnmacht et al. 2016), and glucocorticoid signalling was detected in ERGs of 
lesioned fish, suggesting the impaired regeneration may be due in part to a direct 
effect on ERGs (Nelson et al. 2018). However, I found no differences in ERG 
proliferation or Th+ neurogenesis between sham and sham + dex fish (Figure 4. 3, 




or Th+ neurogenesis in the brains of adult zebrafish at least in a non-regeneration 
context. This is in keeping with previously published results showing no effect of 
dexamethasone treatment on constitutive ERG proliferation or neurogenesis in the 
telencephalon (Kyritsis et al. 2012). Instead, inhibition of the immune system only 
affected the production of new Th+ cells after ablation (Figure 4. 3, Figure 4. 4). This 
is likely because in the sham condition there is not a significant immune response to 
inhibit.  
Dexamethasone treatment has also been shown to protect against dopaminergic 
cell death in mammalian models (Kurkowska-Jastrzębska et al. 2004). I chose to 
begin the dexamethasone treatment 24 hours after the injection of 6OHDA, and 
fish were immersed in dexamethasone for 2 weeks to suppress as much of the 
immune response as possible during regeneration. From my results presented 
here (Figure 4. 8), the number of Th+ cells was unchanged in dexamethasone 
treated animals, indicating that the drug treatments I used did not significantly 
affect the survival of mature Th+ neurons. In the salamander, dexamethasone 
treatment decreased the number of TUNEL+/Th+ cells at 4 days post injection of 
6OHDA (Kirkham et al. 2011). As this is after the initial period of 6OHDA-induced 
cell death (1-3 dpi) this was interpreted as an indication that immunosuppression 
promotes the survival of newly forming Th+ cells. Here I showed that the number 
of Th+/EdU+ cells was unchanged by dexamethasone treatment (Figure 4. 8), 
indicating that the survival of newly generated Th+ neurons in the zebrafish brain 
is also unaffected by dexamethasone treatment.   
I sought to assess the regenerative capacity of dopaminergic neurons in the absence 
of microglia to corroborate the inhibitory effect of dexamethasone on the regeneration 
of Th+ neurons and thus provide more evidence for a requirement of an immune 




in Irf8-/- fish, which have been shown to have fewer microglia during development 
(Shiau et al. 2015). However, the numbers of microglia in the adult zebrafish brain 
were similar (Figure 4. 9), and so this mutant is not a useful tool for investigating an 
impaired immune response in this context.  
A potential solution would be to use csf1ra/b mutants which have also been shown to 
have very few microglia in larvae (Tsarouchas et al. 2018). If this phenotype continues 
into adulthood these fish could be used to assess Th+ neuroregeneration in the 
absence of microglia. This would determine whether 6OHDA-induced proliferation of 
ERGs is wholly dependent on the immune system or if there are other mechanisms 
in play which allow ERGs to respond to 6OHDA-induced ablation of Th+ neurons 
which are also affected by dexamethasone treatment.   
4.3.4 An immune response is sufficient to increase ERG proliferation but not 
neurogenesis of Th+ cells 
Zymosan increased proliferation of ERGs in sham animals, demonstrating that it was 
able to have an effect (Figure 4. 6). Similarly, injection of zymosan increased ERG 
proliferation in the adult zebrafish telencephalon and cerebellum (Kyritsis et al. 2012). 
Furthermore, injection of specific pro-inflammatory cytokines il-4 and LTC4 have been 
shown to increase ERG proliferation in the zebrafish brain (Kyritsis et al. 2012; 
Bhattarai et al. 2016), further demonstrating a link between activation of the immune 
system and ERG proliferation. 
Although stimulating the immune response with zymosan in the sham condition is 
sufficient to increase proliferation of ERGs (Figure 4. 6), the number of newly formed 
Th+ cells is unchanged (Figure 4. 8). In the  telencephalon and cerebellum, zymosan 
injections increased the number of new neurons, colabelled with the pan-neuronal 




around the diencephalic ventricle could determine whether zymosan has an effect on 
neurogenesis in this brain region, even if the generation of Th+ cells in particular is 
not increased.Zymosan may induce proliferation of ERGs, but in the absence of 
ablation there is no deficit of Th+ neurons to specifically promote the generation of 
new Th+ neurons in population 5/6. Instead, these EdU+ ERGs may be self-renewing, 
or generating a range of other neuronal subtypes, or the newly formed cells may be 
relatively short lived as they are not required. Moreover, it could be speculated that if 
there is no deficit of Th+ neurons in the 5/6 population there could be limited trophic 
support for supernumerary neurons, preventing an increased number of new neurons 
from being added to population 5/6.  
Activation of microglia with zymosan did not enhance ERG proliferation or Th+ 
neurogenesis in 6OHDA-injected fish (Figure 4. 6, Figure 4. 7).  
Both 6OHDA and zymosan elicited an immune response (Figure 4. 2, Figure 4. 5), 
and both drugs increased ERG proliferation when used separately. Although the 
magnitude of the immune response caused by zymosan appeared to be much 
higher than 6OHDA, the increase in ERG proliferation was comparable (Figure 4. 
6). This suggests that although ERGs can proliferate in response to immune 
activation there is a limit to the number of proliferating cells, and this is already 
reached at the level of immune activation caused by injection of 6OHDA. 
Presumably, co-injecting fish with 6OHDA and zymosan elicits an even greater 
immune response than either drug alone, and this could be confirmed with 
quantitative RT-PCR. However, if ERGs are already responding maximally to 
immune activation, this explains why enhancing the immune response even 




To assess the increase in cytokine expression after zymosan injection I  selected 
a time point of 12 hpi as this was found to be the peak of expression of tnf-α and 
il-1β (Kyritsis et al. 2012). Although the variability of the results obscured the 
effect (Figure 4. 5), the means, SEMs and p values of the data suggest that if more 
fish were included then the results may reach significance (fold increase 
compared to sham injected fish, tnf-α: 46.89 ± 24.63 (p=0.2035), il-1β: 49.06 ± 22.31 
(p=0.1641)). As there is published data showing the expression of these  cytokines 
are increased after zymosan injection (Kyritsis et al. 2012), and that there is an 
increase in the labelling of L-plastin+ cells (Kyritsis et al. 2012) in zymosan 
injected fish, this suggests that zymosan injections do cause a microglial 
repsonse. 
Zymosan acts through toll-like receptor 2 (TLR2), a transmembrane receptor found 
on immune cells, including microglia (Underhill 2003), but also expressed by human 
neural stem cells (Grasselli et al. 2018; Rolls et al. 2007). From the data in this thesis 
I cannot exclude that there may be a direct action of zymosan on ERGs, and this 
could influence their proliferation independent of microglial activation. If TLRs are 
expressed by ERGs at the diencephalic ventricle in zebrafish, treating isolated ERGs 
with zymosan and measuring the proliferation or changes in gene expression in these 
cells could determine whether this is a possible mechanism by which zymosan was 
influencing ERG proliferation. Alternatively, assessing the proliferation of ERGs in 
csf1ra/b mutants with significantly fewer microglia could also answer this question 
(Tsarouchas et al. 2018).  
4.3.5 Investigations into the molecular signals triggering increased ERG 
proliferation 
These results suggest proliferation of ERGs around the ventricle can be regulated by 




myriad of signalling molecules, and any one of these (or a combination) may be the 
signal between microglia and progenitor cells in our system.  In addition, cytokines 
often attract other immune cells, and so a requirement for any particular cytokine(s) 
would need to be tested in a system devoid of microglia. 
In an effort to elucidate the molecular signals involved in the regeneration of 
dopaminergic neurons I adopted three pharmacological approaches based on the 
literature regarding regeneration in the adult zebrafish brain and the regeneration of 
Th+ neurons in the adult salamander brain.  
4.3.5.1 LTC4 
As discussed in the introduction to this chapter, LTC4 was shown to be sufficient for 
increased neurogenesis in the adult zebrafish telencephalon, and required for lesion-
induced neurogenesis (Kyritsis et al. 2012). 
LTC4 elicited a response from microglial cells, demonstrated by the increased 4C4 
labelling around the diencephalic ventricle compared to vehicle injected fish (Figure 
4. 10). This is in contrast to published data which shows that LTC4 does not cause a 
microglial response in comparison to vehicle injected fish (Kyritsis et al. 2012). 
However, the vehicle in that case was methanol, which may induce neuronal death 
and could cause an immune response itself. To prevent a vehicle-mediated 
microglial reaction, I used LTC4 supplied in 95% ethanol in water. After diluting this 
with water to the desired concentration of drug, the percentage of ethanol in the 
injected solution was only 0.45%. I demonstrated that this vehicle did not induce an 
immune response, as there was no difference in the 4C4 labelling between vehicle-
injected and uninjected fish.  
The increased 4C4 labelling after injection of LTC4 demonstrates that the treatment 




identical concentration of LTC4 to what was shown to increase proliferation of ERGs 
in the telencephalon (Kyritsis et al. 2012), Karolina and I did not observe an effect of 
LTC4 on the number of PCNA+ ERGs at the ventricle. This could be a consequence 
of analysing different areas of the brain, and ERGs in the telencephalon may be more 
responsive to LTC4.  
LTC4 elicited an immune response but we did not observe any change to the 
number of proliferating ERGs (Figure 4.10, Figure 4. 11). Zymosan also causes in 
an immune response (Figure 4. 5), however in this case this was accompanied by 
an increase in proliferating ERGs (Figure 4. 6). This difference could be a result of 
the different magnitude of microglial activation. Although the data presented here do 
not allow for a direct comparison, qualitatively the difference in 4C4 labelling 
between sham injected brains and zymosan injected brains is more pronounced 
than the comparisons between vehicle and LTC4 injected brains (Figure 4. 5 
compared to (Caldwell and Davies et al. 2018)). Quantitative RT-PCR for pro-
inflammatory cytokines after LTC4 injection could determine whether this is a valid 
point.  
Another consideration is that the proliferation of ERGs after zymosan and LTC4 was 
measured in different ways, (EdU labelling and PCNA labelling, respectively), and 
with different experimental timelines (Figure 4. 5 and Figure 4. 11). Therefore a 
separate experiment with identical readouts and timelines would be required for a 
direct comparison between the two compounds in terms of ERG proliferation.  
An immune reaction is necessary for the proliferation of ERGs after ablation (Figure 
4. 3), and for the full regeneration of Th+ neurons (Figure 4. 4). It is possible that LTC4 
could be the molecule mediating this effect, by promoting a microglial response to 




shown to be required for lesion-induced ERG proliferation and neurogenesis after a 
stab injury to the telencephalon (Kyritsis et al. 2012). Along with tnf-α and il-1β, LTC4 
signalling may be increased after injection of 6OHDA and could be one of the 
molecular signals involved in eliciting a microglial response. This hypothesis could be 
tested first by assessing the level of leukotriene C4 signalling through quantitative RT-
PCR for CysLT1 to determine whether there is an increase in LTC4 signalling in 
6OHDA injected fish compared to sham injected fish. To test whether LTC4 is required 
for regeneration of Th+ neurons one could treat 6OHDA-injected fish with the CysLT1 
receptor antagonist pranlukast and count the numbers of proliferating ERGs and new 
Th+ cells. If pranlukast did inhibit Th+ regeneration one could then aim to distinguish 
whether LTC4 signalling is required for microglial activation which then influences 
ERG proliferation, or to stimulate ERGs directly. This could be tested by assessing 
the immune response in 6OHDA-injected fish treated with pranlukast compared to 
6OHDA alone. If LTC4 signalling is required to elicit an immune response, the level 
of pro-inflammatory cytokines measured by quantitative RT-PCR and the level of 4C4 
labelling would be lower in pranlukast treated fish.  
4.3.5.2 Haloperidol 
I observed no difference in the number of proliferating cells lining the ventricle after 
injection of the dopamine receptor antagonist haloperidol (Figure 4. 14). In 
salamanders, 6OHDA-induced ablation of the dopaminergic innervation to the 
forebrain results in decreased proliferation of progenitor cells in the striatum (Joven 
et al. 2018), whereas haloperidol increases proliferation of Th+ neuron progenitor cells 
in the midbrain (Berg et al. 2011). This indicates that there may be region-specific 
effects of dopamine signalling on progenitor cell proliferation. Progenitor cells in areas 
of the brain where there is no constitutive proliferation, such as the salamander 




progenitors in the salamander forebrain and lining the diencephalic ventricle of the 
zebrafish brain, as described here, may be unresponsive to a reduction in dopamine. 
However, as there are no dopaminergic neurons in the zebrafish midbrain it is not 
possible to test whether haloperidol would affect the neurogenesis of dopaminergic 
neurons in this area of the brain in zebrafish.  
As I obtained a negative result it is also possible that this discrepancy is a result of 
technical issues. In order to deliver a sufficient dose of haloperidol to the brain I 
followed the method used to significantly affect the regeneration of dopaminergic 
neurons in the salamander (Berg et al. 2011). I injected fish with haloperidol obtained 
from the same company with the same catalogue number, and at twice the 
concentration for 6 days rather than 4 days. This implies that the administration of 
haloperidol should have been sufficient to deliver at least a similar level of haloperidol 
to ERGs in the brain.  
In situ hybridisation showed that mRNA for d4a, the gene encoding one of the D2 
dopamine receptors, is upregulated around the central canal in the zebrafish spinal 
cord after a lesion (Reimer et al. 2013). Moreover, dopamine receptor antagonists, 
including haloperidol, have been shown to affect neurogenesis in the zebrafish CNS 
(Reimer et al. 2013). Although these results suggest dopamine receptors are present 
on ERGs in the zebrafish spinal cord, it is not known whether ERGs in the adult 
zebrafish brain also have dopamine receptors. It is therefore possible that haloperidol 
did not affect ERG proliferation in my experiments due to the absence of dopamine 
receptors on ERGs at the diencephalic ventricle. The presence of these receptors 
could be determined by in situ hybridisation or immunohistochemistry combined with 




A limitation of this experiment is that the proliferation was quantified by counting the 
number of EdU+ cells lining the ventricle without any marker for ERGs (e.g. gfap, olig2, 
her4). While the vast majority of cells lining the ventricle are likely ERGs, I have 
observed other EdU+ cell types around the ventricle, for example microglia, which may 
have also been counted and affected the results. If this experiment were to be 
repeated, Tg(gfap:GFP;olig2:Dsred) could be used to identify EdU+ ERGs and 
exclude any other EdU+ cell types.  
Activation of the immune system with zymosan was sufficient to increase proliferation 
of ERGs; however, the number of Th+ neurons was unchanged, as discussed above. 
On the other hand, manipulating dopamine signalling with haloperidol did not affect 
the proliferation at the ventricle. I hypothesised that dopamine signalling may be able 
to promote Th+ neurogenesis through an alternative method to increased ERG 
proliferation, for example promoting a Th+ specification in newly formed neurons.  
To test this hypothesis I used zymosan to induce proliferation of ERGs and treated 
fish with haloperidol to encourage cells to adopt a Th+ cell fate. However, there was 
no effect of this treatment on the number of Th+/EdU+ cells compared to zymosan 
treatment alone. This suggests that dopamine signalling may not regulate Th+ 
neurogenesis in the adult zebrafish brain as it does in the midbrain of the salamander. 
4.3.5.3 Pomalidomide treatment does not affect the proliferation of ERGs or 
the regeneration of Th+ neurons 
Injection of 6OHDA causes an increase in the level of the pro-inflammatory cytokine 
tnf-α (Figure 4. 2). It has been shown previously that tnf-α is required for injury-induced 
proliferation of progenitor cells in the adult zebrafish retina (Nelson et al. 2013), and 
injection of tnf-α into the uninjured retina promotes neurogenesis (Conner et al. 2014). 




Th+ neurons. However, inhibiting the release of tnf-α with pomalidomide did not affect 
the number of proliferating ERGs or the number of Th+/EdU+ or overall Th+ cells in 
population 5/6 (Figure 4. 12, Figure 4. 13).  
As with any negative result the first question is whether pomalidomide was exerting 
an effect on tnf-α signalling in the brain. The concentration of pomalidomide used was 
determined by considering the IC50 of the drug and reports that around 39% passes 
through the blood brain barrier (Li et al. 2013). Previous results from our lab and 
others (Mahony et al. 2013; Tsarouchas et al. 2018) have shown that immersion of 
zebrafish larvae in pomalidomide is able to have biological effects. However, 
determining whether pomalidomide is actually reducing tnf-α signalling cannot be 
achieved simply by measuring the levels of tnf-α after treatment, because there is 
conflicting evidence showing the level of tnf-α mRNA is reduced, unchanged, or 
increased by pomalidomide. Instead, a more appropriate readout for the action of 
pomalidomide would be to examine the levels of downstream molecules of tnf-α 
signalling, for example NF-κB (Schütze et al. 1995). 
Even if there was an effect of pomalidomide on the regeneration of Th+ neurons, this 
would not be enough evidence to suggest tnf-a specifically is required for the 
regeneration of Th+ neurons. tnf-α is known to attract immune cells (Ming et al. 1987), 
and as such an inhibitor of tnf-a signalling would act as an immunosuppressant, 
therefore likely having similar effects as dexamethasone, impairing the regeneration 
of Th+ neurons. To demonstrate that tnf-α could have a direct effect on the ERGs one 
would first have to show that at least one of the receptors for tnf-α is expressed by 
ERGs at the ventricle, for example by in situ hybridisation combined with markers for 
ERGs. Secondly, one would need to show that pomalidomide can affect the 




after fluorescent assisted cell sorting (FACS) for ERGs or in csfr1a/b mutants lacking 
microglia (Tsarouchas et al. 2018).   
4.3.5.4 Future investigation into candidate cytokines  
Inhibition of tnf-α signalling did not affect proliferation of ERGs or regeneration of Th+ 
neurons (Figure 4. 12, Figure 4. 13), however, I also observed a 6OHDA-induced 
increase in il-1β (Figure 4. 2), demonstrating that tnf-α is not the only cytokine 
affected. In larval zebrafish, il-1β signalling has been shown to influence the axonal 
regeneration and functional recovery after spinal cord transection (Tsarouchas et al. 
2018).   
Moreover, the cytokine interleukin 4 (il-4) has been suggested to increase 
neurogenesis in the telencephalon, acting through a pathway separate to LTC4 
(Bhattarai et al. 2016). This cytokine is upregulated in brains injected with the fast 
accumulating amyloid beta peptide TR-Aβ42, which is similar to our 6OHDA model in 
that neuronal cell death is induced without a traumatic brain injury in the adult 
zebrafish brain. Il-4 was also shown to be sufficient to increase the number of 
proliferating ERGs and new neurons formed in unlesioned brains. In TR-Aβ42-
injected brains, a morpholino against il-4 was shown to reduce the number of 
proliferating ERGs, suggesting that il-4 may be required for ERG proliferation, 
although it may also be involved in microglial activation. It would therefore be 
interesting to assess the effect of il-4 on ERG proliferation in the absence of microglia. 
This could be achieved using fluorescence-activated cell sorting (FACS) to isolate 
ERGs, and then assessing their level of proliferation in response to il-4 treatment. 
Alternatively, the effect of il-4 in vivo could be tested by injecting il-4 into csfr1a/b 
mutants lacking microglia (Tsarouchas et al. 2018) and counting the numbers of EdU+ 





From the data presented in this chapter, I conclude that injection of 6OHDA causes 
an immune response involving microglia and leads to increased proliferation of ERGs. 
This immune response is necessary for the successful regeneration of Th+ neurons. 
In the absence of ablation, an immune response is sufficient to increase ERG 
proliferation but not Th+ neurogenesis. These conclusions are summarised in a 
schematic (Figure 4. 16). 
The molecular mechanism for how microglial activation impacts ERG proliferation and 
regeneration of Th+ neurons is yet to be elucidated. I found no evidence for an effect 
of haloperidol injections, LTC4 injections, or pomalidomide treatment; however, this 
does not rule out a contribution of dopamine signalling or cytokine signalling on the 






Figure 4. 16 Schematic overview of results, adapted from (Caldwell and Davies et al. 2018). Ablation 
of Th+ neurons with 6OHDA elicits a microglia response, which is necessary for regeneration of 
new dopaminergic neurons from ERGs. Ablation-induced proliferation of ERGs and 
neurogenesis of Th+ neurons is inhibited by dexamethasone. Zymosan stimulates ERG 
proliferation, but does not affect the neurogenesis of Th+ neurons. The question mark represents 
the remaining uncertainty in the signal linking proliferating ERGs to increased neurogenesis of 








Chapter Five: Investigating Alternative 
Methods of Th+ Neuron Ablation 
5.1. Introduction  
The dopamine homologue 6OHDA specifically ablates Th+ neurons in population 5/6, 
population 11, population 12, and the locus coeruleus, and these populations have 
varying capacities to be regenerated (Caldwell and Davies et al. 2018). On the other 
hand, populations 2, 7, 9, 13, and 15/16 were unaffected by injection of 6OHDA. I 
reasoned that alternative methods used to ablate dopaminergic neurons may affect 
Th+ populations which were unaffected by 6OHDA, and that this would allow me to 
investigate the regenerative capacity of these populations. Three distinct approaches 
were adopted: a genetic manipulation, a chemogenetic ablation, and chemical 
ablation.  
5.1.1 Genetic manipulation to reduce the number of dopaminergic neurons: 
pink1 
Genetic mutations are responsible for approximately 10% Parkinson’s disease cases 
(Klein & Westenberger 2012). For example, mutations in PINK1 (PTEN-induced 
putative kinase 1) are the second most common cause of autosomal recessive 
Parkinson’s (Valente et al. 2004; Li et al. 2005; Mills et al. 2008). PINK1 encodes a 
mitochondrial serine/threonine kinase and is widely expressed in the human brain 
(Gandhi et al. 2006). Parkinson’s disease-causing mutations in PINK1 have been 
shown to result in a loss of function of PINK1 (Sim et al. 2006), which appears to 
increase the susceptibility of dopaminergic neurons to oxidative stress (Cookson 
2012). Hence a number of pink1 knockout animal models have been generated in 





Pink1 knockout mice do not exhibit any gross morphological abnormalities. Most 
notably, no abnormalities were found in the dopaminergic system of pink1 knockout 
mice, and the numbers of Th+ neurons, the levels of striatal dopamine, and the levels 
of dopamine receptors are comparable to wildtype control mice (Kitada et al. 2007). 
In contrast, loss of function mutations in pink1 in drosophila result in dopaminergic 
cell death, along with a range of other phenotypes, including muscle degeneration, 
an inability to fly, slower climbing speeds, loss of photoreceptors, male sterility, and 
increased sensitivity to stressors (Clark et al. 2006; Park et al. 2006; Yang et al. 2006). 
The observed phenotypes were rescued by the introduction of human PINK1, 
demonstrating that these wide-ranging phenotypes were pink1-dependent, and that 
the gene is functionally conserved between drosophila and humans.  
The effect of pink1 depletion in zebrafish has been investigated primarily using 
morpholinos (Anichtchik et al. 2008; Sallinen et al. 2010; Xi et al. 2010; Ryu et al. 
2007). These studies have reported variable effects on dopaminergic neurons, from 
subtle alterations in Th+ projections from intact nuclei (Xi et al. 2010) to reduced 
numbers of Th+ neurons (Anichtchik et al. 2008). However, it is important to note that 
some of these studies have reported gross morphological abnormalities and 
generalised increases in cell death, (Anichtchik et al. 2008; Xi et al. 2010), suggesting 
toxicity of the morpholino which is not specific to pink1 deficiency.  
Furthermore, morpholinos are most efficient at inhibiting translation during the first 2-
3 days of development (Sumanas & Larson 2002), restricting the time available for 
phenotypic analysis. Therefore a stable transgenic line has been generated in which 
there is a premature stop codon in the kinase-encoding domain of pink1 (Flinn et al. 
2013). At 5 dpf pink1-/- larvae had 25% fewer Th+ neurons and 30% fewer dat+ neurons 
than wildtype controls. No differences were observed in the expression patterns of 




However, cell numbers of other neuronal populations, for example serotonergic 
neurons, could have been compared to age-matched wildtype controls to provide a 
better control for normal neurodevelopment. Adult pink1-/- zebrafish were reported to 
have 50% fewer Th+ neurons in the posterior tuberculum. The greater difference in 
Th+ neurons in adults compared to larvae suggested that these fish may have a 
progressive loss of dopaminergic neurons. In addition, a higher number of 
apoliloprotein E (ApoE)+ cells was observed in pink1-/- fish at 3 dpf, which was 
interpreted as an indicator of microglial activation. However, it is not clear whether the 
reduced numbers of Th+ neurons in pink1-/- fish are a result of fewer dopaminergic 
neurons being produced, or a result of dopaminergic cell death.  
5.1.2 Chemogenetic ablation of dopaminergic neurons 
While genetic ablation can specifically target a certain population of cells, 
chemogenetic ablation also allows for temporal control. This means an animal can 
develop normally without potentially deleterious effects of mutations, and ablation can 
be induced at a specific time point. Several different approaches have been 
developed for chemogenetic ablation, but in this chapter I will focus on the 
nitroreductase system, which has been used extensively in zebrafish (Curado et al. 
2008).  
Nitroreductase (NTR), an enzyme isolated from Escherichia coli, is expressed under 
a tissue-specific promoter, often in combination with a fluorescent reporter gene. 
Upon application of a non-toxic substrate, nitroreductase converts the prodrug into a 
DNA interstrand cross-linking agent, inducing apoptotic cell death (Lindmark & Müller 
1976). A reduction in the number of fluorescent cells can be used as an indicator of 
successful ablation. The previously used substrate of nitroreductase, CB1954 [5-
(aziridin-1-yl)-2,4-dinitrobenzamide], was shown to have bystander effects, killing 




et al. 1997; Helsby et al. 2004). However, the toxic metabolite of metronidazole is 
confined to the NTR-expressing cell, and thus specifically ablates only cells 
expressing the nitroreductase enzyme (Pisharath et al. 2007; Curado et al. 2008).  
Two independent groups pioneered the use of the nitroreductase system to ablate 
cells and study their regeneration in zebrafish (Curado et al. 2007; Pisharath et al. 
2007). Since then, the nitroreductase system has been used to investigate 
regeneration of a variety of different tissues in zebrafish, including cardiomyocytes 
(Curado et al. 2007; Zhang et al. 2013), pancreatic β-cells (Curado et al. 2007; 
Pisharath et al. 2007; Moss et al. 2009), hepatocytes (Curado et al. 2007; Choi et al. 
2015), osteoblasts (Singh et al. 2012), skin cells (Chen et al. 2011), ovaries (White et 
al. 2011), podocytes (Huang et al. 2013; Zhou & Hildebrandt 2012) and 
oligodendrocytes (Chung et al. 2013).  
Furthermore, metronidazole has been shown to cross the blood brain barrier (Nau et 
al. 2010), and unlike other methods of chemogenetic ablation, nitroreductase is cell 
cycle independent. This means that this is a suitable method to ablate even non-
dividing cells, such as neurons. In zebrafish, metronidazole treatment has been 
shown to induce specific ablation of neurons including serotonergic neurons of the 
dorsal raphe, the habenular, otpa+ neurons of the hypothalamus, and motor neurons 
in the spinal cord (Yokogawa et al. 2012; Agetsuma et al. 2010; Lambert et al. 2012; 
van Ham et al. 2012; Ohnmacht et al. 2016). 
Importantly, the NTR system is appropriate for regeneration studies, as withdrawal of 
metronidazole removes the cytotoxic agent, and the affected tissue can recover. The 
extent of regeneration can then be assessed both by a recovery in the numbers of 
fluorescent cells, and by labelling newly generated cells (Curado et al. 2007; Godoy 




Ohnmacht et al. 2016; Huang et al. 2013). Previous regeneration studies in zebrafish 
using this system have demonstrated that tissue regeneration following exposure to 
metronidazole results in functional recovery, indicating that there are no deleterious 
after effects of metronidazole treatment.  
In this chapter I use fish expressing nitroreductase and a fluorescent reporter under 
the control of the promoter for a gene encoding the homeodomain transcription factor 
orthopedia b (otpb) (Lambert et al. 2012). This promoter drives expression in 
diencephalic Th+ neurons in larvae (primarily DC4 and DC6, based on the 
nomenclature (Rink & Wullimann 2002)), as well as non-dopaminergic Th- neurons in 
the rostral diencephalon (Fujimoto et al. 2011), essentially recapitulating the 
expression pattern of the endogenous otpb gene in zebrafish (Ryu et al. 2007; 
Kastenhuber et al. 2009; Tay et al. 2011b). Successful ablation has been achieved 
by immersing larval zebrafish in metronidazole, demonstrated by an 88% decrease in 
the number of Th+/GFP+ cells and the presence of TUNEL+/GFP+ cells in 
metronidazole treated larvae (Lambert et al. 2012).   
5.1.3 Chemical ablation of dopaminergic neurons: MPTP and MPP+ 
In addition to 6OHDA there are a number of other chemicals which have been shown 
to selectively kill dopaminergic neurons in vivo (Betarbet et al. 2002). One of the most 
commonly used toxins is 1-methyl-1,2,3,6-tetrahydropyridine (MPTP). The ability of 
MPTP to kill dopaminergic neurons was first discovered in patients presenting with 
Parkinson’s disease like symptoms after injecting mis-synthesised heroin (Langston 
et al. 1983). It was subsequently found that MPTP could selectively ablate 
dopaminergic neurons to model Parkinson’s disease in animals, including primates 
(Fox & Brotchie 2010), cats (Schneider & Markham 1986), rodents (Heikkila et al. 
1984), salamanders (Barbeau et al. 1985), fish (Weinreb & Youdim 2007; Bretaud et 




MPTP is able to cross the blood brain barrier, after which it is converted to its toxic 
metabolite N-methyl-4-phenylpyridine (MPP+) by monoamine oxidase (MAO) in glial 
cells (Langston et al. 1984; Chiba et al. 1984). MPP+ enters dopaminergic neurons 
through the dopamine transporter ((Miller et al. 1999), where it inhibits complex 1 of 
the mitochondrial respiratory chain (Nicklas et al. 1985), leading to cell death.  
In zebrafish larvae, the effects of MPTP and MPP+ have had conflicting effects on the 
dopaminergic system, with some studies reporting gross morphological abnormalities 
with concentrations others used to demonstrate a reduced number of Th+ neurons 
post treatment (Bretaud et al. 2004; McKinley et al. 2005; Lam et al. 2005; Sallinen et 
al. 2009; Thirumalai & Cline 2008; Xi et al. 2011; Dukes et al. 2016). As none of these 
studies found evidence for dopaminergic cell death, it is possible that MPTP and 
MPP+ treated larvae have been reported to have fewer dopaminergic neurons due to 
impaired neurodevelopment rather than selective ablation of Th+ cells.  
MPTP has been shown to reduce the number of Th+ neurons in the adult goldfish 
brain (Poli et al. 1990; Goping et al. 1995). The amounts of dopamine and 
noradrenaline in the brain were also reduced by MPTP injection (Poli et al. 1990; 
Youdim et al. 1992), but recover within 10-13 days post treatment (Pollard et al. 
1992). This was accompanied by profound bradykinesia which also recovered, 
suggesting functional regeneration of Th+ neurons. Although the behavioural 
deficits have also been reported in adult zebrafish injected with MPTP, there is not 
currently any evidence of a reduction in the number of Th+ neurons (Anichtchik et 







5.2.1 Genetic manipulation to reduce the number of dopaminergic neurons: 
pink1 
5.2.1.1 Th+ cell numbers in the diencephalon were comparable in pink1+/+ and 
pink1-/- fish 
Pink1-/- zebrafish were found to have fewer Th+ cells at 5 dpf compared to wildtype 
larvae (Flinn et al. 2013). We wanted to investigate whether this might be a result of 
delayed development of Th+ neurons or a loss of Th+ cells. To this end, we obtained 
pink1-/- fish and pink1+/+ fish from the authors of this paper, and confirmed their 
genotypes by sequencing DNA extracted from a fin clip sample (Figure 5. 1A). 
Together with Adelina Haller, a masters student under my supervision, I compared 
the numbers of Th+ cells were between wildtype (pink1+/+) and homozygous mutant 
(pink1-/-) zebrafish at 2, 3, 4, and 5 dpf. We found no significant difference in the 
numbers of Th+ neurons at any of the time points analysed (Figure 5. 1, 2 dpf pink1+/+: 
56.12 ± 2.497, 2 dpf pink1-/-: 55.13 ± 2.641, 3 dpf pink1+/+: 92.86 ± 4.234, 3 dpf pink1-
/-: 82.71 ± 3.435, 4 dpf pink1+/+: 96.33 ± 4.910, 4 dpf pink1-/-: 83.86 ± 5.235, 5 dpf 
pink1+/+: 87.80 ± 2.611, 5 dpf pink1-/-: 93.25 ± 7.409), suggesting that pink1 does not 





Figure 5. 1 No difference was found in the number of Th+ neurons in the diencephalon of larval 
zebrafish in pink1+/+ and pink1-/- neurons. A: Chromatograms of pink1+/+ (upper panel) and pink1-
/- (lower panel) sequences, showing the T>G change, highlighted. B: Maximum projections of Th+ 
cells in the diencephalon from a dorsal view (rostral is up). C: Quantification of the numbers of 
Th+ cells at 2, 3, 4, and 5 days post-fertilisation (dpf). Student’s t test and Mann Whitney U tests 




5.2.1.2 Microglia numbers were higher in pink1-/- larvae compared to pink1+/+ 
It has been shown previously that pink1-/- larvae have more ApoE+ cells compared to 
pink1+/+ larvae, which suggests activation of the immune system (Flinn et al. 2013). 
To investigate this phenotype further I compared the numbers of microglia in pink1-/- 
larvae and wildtype larvae by counting the number of 4C4+ cells in confocal z-stacks 
containing the entire diencephalon. I found that the number of 4C4+ cells in the 
diencephalon was 63.4% higher in pink1-/- larvae at 4 dpf compared to pink1+/+ larvae 
(Figure 5. 2, pink1+/+: 100.5 ± 4.291, pink1-/-: 164.2 ± 13.00), indicating that there is 
an immune response.   
 
Figure 5. 2 pink1-/- fish have more microglia than wildtype larvae. A: pink1-/- larvae have more 4C4+ 




left). B: Quantification of the number of 4C4+ cells. Mann Whitney U test, **p < 0.01. Scale bar = 
100 µm. 
5.2.2 Chemogenetic ablation of dopaminergic neurons 
5.2.2.1 Tg(otpb:NTR-GFP) zebrafish have GFP+ in the adult brain, and these 
overlap with Th+ populations in some cases 
Tg(otpb:NTR-GFP) fish have been used to ablate Th+ neurons in the diencephalon of 
zebrafish larvae (Lambert et al. 2012). To investigate the feasibility of using these fish 
to ablate Th+ neurons in adult zebrafish I first compared the localisation of GFP+ cells 
with Th+ populations in sagittal sections of the adult zebrafish brain and found that the 
populations were different but overlapping (Figure 5. 3).  
Double-positive Th+/GFP+ cells were present in population 12, population 13, and the 
locus coeruleus, although not all Th+ cells in these populations were GFP+ (population 
12: 97.5% population 13: 34.9%, locus coeruleus: 28.6% Th+ cells were also GFP+).  
In contrast, no GFP+ cells were found in other Th+ populations. For example, GFP+ 
cells were seen in proximity to population 3/4, but no Th+/GFP+ cells were observed 





Figure 5. 3 There are different but overlapping populations of Th+ and GFP+ cells in the brains of 
adult otpb:NTR-GFP zebrafish. GFP+ cells are seen in proximity to population 3/4. Population 12, 
population13, and the locus coeruleus all contain Th+/GFP+ cells. Scale bar for top row = 50 µm, 




5.2.2.2 Immersion of adult zebrafish in metronidazole did not affect GFP+ axons 
in the spinal cord 
Immersion of otpb:NTR-GFP larvae in metronidazole induced dopaminergic cell death 
(Lambert et al. 2012). Metronidazole immersion has also been used to ablate NTR+ 
cells in the CNS of adult zebrafish (Agetsuma et al. 2010; Soares Godoy 2015). I 
therefore sought to ablate cells in otpb:NTR-GFP adults by immersing the fish in 
metronidazole. In larvae, otpb:NTR-GFP+ cells comprise the dopaminergic 
diencephalospinal tract (Lambert et al. 2012), and the presence of GFP+ cells and 
axons in population 12 and the locus coeruleus demonstrates Th+/GFP+ axons also 
project to targets in the spinal cord in adulthood (Figure 5. 3). The absence of these 
axonal projections in the spinal cord can be used to determine the success of 6OHDA-
induced ablation of Th+ cells in the adult zebrafish brain. Hence, I assessed the 
success of metronidazole-induced ablation by comparing GFP+ axons in the spinal 
cord. However, by qualitative observation, I detected no difference in the abundance 
of GFP+ axons in fish immersed in metronidazole compared to vehicle treated controls 





Figure 5. 4 No difference was observed between GFP+ axons in the spinal cord of adult zebrafish 
immersed in metronidazole and vehicle treated controls. A: The experimental timeline is given. 
B: Maximum projections of GFP+ axons in coronal sections of the adult spinal cord (dorsal is up). 
Scale bar = 100 µm.   
 
5.2.2.3 Injection of metronidazole into adult zebrafish did not affect GFP+ axons 
in the spinal cord 
The Th+ cells in population 12 and the locus coeruleus are located deep within the 
brain, and so we hypothesised that the lack of ablation could be due to insufficient 
levels of metronidazole reaching these cells. To avoid this potential issue I 
administered metronidazole by intraperitoneal injection. However, I still observed no 
qualitative difference in GFP+ axons in the spinal cord between metronidazole and 





Figure 5. 5 No apparent difference was observed between GFP+ axons in the spinal cord of adult 
zebrafish injected with metronidazole and vehicle treated controls, assessed by qualitative 
observation. A: The experimental timeline is given. B: Maximum projections of GFP+ axons in 
coronal sections of the adult spinal cord (dorsal is up). Scale bar = 100 µm. 
 
5.2.3 Chemical ablation of dopaminergic neurons: MPTP and MPP+ 
Together with Leonardo Cavone, a postdoctoral researcher in our group, I attempted 
to ablate Th+ neurons using MPTP and MPP+. MPP+ was injected directly into the 
ventricle in the brain, as it does not cross the blood brain barrier, whereas MPTP was 
administered by intraperitoneal injection. However, we observed no difference 
between Th+ axons in MPTP and MPP+ injected fish compared to vehicle injected 
controls, whereas 6OHDA-induced ablation of Th+ cells (used as a positive control) 





Figure 5. 6 No difference was observed in Th+ axons the spinal cords of MPTP and MPP+ injected 
fish compared to vehicle injected fish. A: The experimental timeline is given. B: Maximum 
projections of Th+ axons in coronal sections of the adult spinal cord (dorsal is up). 6OHDA was 
used as a positive control, demonstrating the absence of Th+ axons seen when ablation of 
population 12 is successful. Scale bar = 100 µm. 
 
As Th+ axons in the spinal cord all project from population 12, I also looked at the 
brains of MPTP and MPP+ injected fish to determine whether other Th+ populations 
may be more susceptible to the toxins. However, there were no obvious differences 
in the densities of Th+ cells in population 12, population 13, and the locus coeruleus 
between MPTP and MPP+ injected fish and controls. In the goldfish brain, MPTP 
causes a significant reduction in the level of noradrenaline, and a clear loss of Th+ 
cells in the medulla (Poli et al. 1990), suggesting significant ablation of the locus 
coeruleus. Furthermore, the locus coeruleus has been shown to contain remarkably 
high levels of MAO, the enzyme responsible for the conversion of MPTP into MPP+. I 
therefore reasoned that this population would be most susceptible to MPTP and MPP+ 
toxicity. However, no differences in the Th+ cells in the locus coeruleus was observed 





Figure 5. 7 No difference was observed in Th+ neurons in the locus coeruleus of MPTP and MPP+ 
injected fish compared to vehicle injected fish. A: The experimental timeline is given. B: Maximum 
projections of Th+ neurons in sagittal sections of the adult brain (rostral is left). Scale bar = 50 
µm. 
We used a range of different concentrations of both MPTP and MPP+ in our attempts 
to ablate Th+ cells ( 
Table 5. 1). Higher concentrations of MPP+ resulted in death of the animals, and so 
ablation of Th+ cells could not be determined, but we could be confident that the 
compound was having some biological effect. Lower concentrations of MPP+ and 




Mortality Ablation of 






MPTP 11.5 No No No 
17.3 No No No 




3 No No No 
5 No No No 
7.5 Yes - - 
10 Yes - - 
 
Table 5. 1Summary of attempts to ablate Th+ neurons with MPTP and MPP+. Only MPTP is able to 
permeate the blood brain barrier, and so MPP+ was injected directly into the brain.  
5.3 Discussion 
5.3.1 Genetic manipulation to reduce the number of dopaminergic neurons: 
pink1 
5.3.1.1 We found no differences in the numbers of Th+ neurons in pink1-/- larvae 
compared to wildtype controls  
In this chapter I showed that the number of Th+ cells in pink1-/- larvae were similar to 
wildtype at 2, 3, 4, and 5 dpf (Figure 5. 1). This is in contrast to published results 
showing 25% fewer Th+ cells at 5 dpf compared to wildtype controls (Flinn et al. 2013). 
All of the parent fish we used to breed embryos for this experiment were genotyped 
and confirmed to be pink1-/- (Figure 5. 1A). As there are several different strains of 
“wildtype” zebrafish (Guryev et al. 2006), and there may be variation between these 
strains, we used fish from the TL strain, the same background which was used to 
create the pink1-/- fish, as pink1+/+ controls.  
It is possible that the difference between our results and the previously published data 
could be due to the method used to detect Th+ cells. We detected Th+ cells using  




hybridisation with a probe against Th mRNA (Flinn et al. 2013). Therefore it is possible 
that a lower number of Th+ cells detected by in situ hybridisation could be a result of 
decreased transcription of Th in dopaminergic neurons of pink1-/- larvae.  
An even greater reduction in the number of Th+ cells in population 12 was reported in 
adult pink1-/- fish (Flinn et al. 2013), compared to the difference seen at 5 dpf. However, 
a previous PhD student from our group performed detailed cell counts on each of the 
Th+ populations in adult fish and did not find this reduction (Davies 2016). In both 
cases Th+ cells were counted using Th immunohistochemistry. 
It is possible that the environment the fish were raised in impacted the number of Th+ 
neurons. In many cases, it is thought that a selective loss of dopaminergic neurons in 
patients and in animal models of Parkinson’s disease is a result of genetic factors 
predisposing individuals to environmental toxins (Cannon & Greenamyre 2013).  For 
example, zebrafish injected with pink1 morpholino have fewer Th+ neurons in the 
pretectal area than wildtype fish only when both groups were treated with MPTP, 
demonstrating an increased susceptibility to environmental stressors (Sallinen et al. 
2010). It is possible that fish in the published study (Flinn et al. 2013) were exposed 
to an unidentified environmental factor which was not present in our zebrafish facility.  
There are a number of other Parkinson’s disease-associated genes which when 
manipulated in animals result in fewer dopaminergic neurons (Dawson et al. 2010). 
However, the lack of a reduction in Th + neurons I described here is consistent with 
other zebrafish models in which genes related to Parkinson’s disease do not affect 
the numbers of dopaminergic neurons. For example, disruption of the Leucine-Rich 
Repeat Kinase 2 (LRRK2) encoding gene does not have a specific effect on the 
number of dopaminergic neurons in zebrafish. Morpholino-mediated knockdown 




or a decrease in Th+ cells which was accompanied by a general increase in apoptotic 
cells throughout the whole fish (Sheng et al. 2010). LRRK2-/- zebrafish have reduced 
neurogenesis during development and after a stab lesion to the telencephalon, 
however no defects specific to dopaminergic neurons was found (Suzzi et al. 2017). 
Similarly, knockdown of parkin and DJ-1 also had comparable numbers of 
dopaminergic neurons to controls (Fett et al. 2010; Bretaud et al. 2006). Even 
mutations which cause early-onset Parkinson’s disease do not cause patients to 
develop symptoms for a number of decades (Kilarski et al. 2012), and so it could be 
expected that no loss of dopaminergic neurons is seen in these fish, particularly during 
the first few days of development.  
Furthermore, counting the number of dopaminergic neurons does not distinguish 
between increased death of Th+ neurons and reduced Th+ neurogenesis. In the future 
this could be addressed by combining Th immunohistochemistry with markers for cell 
death, for example TUNEL, and with EdU to assess neurogenesis. The decreased 
generation of Th+ neurons and generalised increased cell death seen in other 
zebrafish genetic models of Parkinson’s disease demonstrate the relevance of this 
point (Sheng et al. 2010; Suzzi et al. 2017). Future experiments with these models 
should take these measures to examine the turnover of Th+ neurons.   
5.3.1.2 pink1-/- larvae have more 4C4+ cells than wildtype controls  
The results presented here show pink1-/- fish had approximately 50% more microglia 
in the diencephalon at 4 dpf compared to wildtype larvae (Figure 5. 2). This is in 
agreement with the 50% increase in ApoE+ cells previously reported in these mutant 
fish (Flinn et al. 2013).  
The microglial phenotype previously reported in pink1-/- fish was present at 3 dpf, 
before the fewer dopaminergic cells at 5 dpf (Flinn et al. 2013). To test whether the 




pink1-/- fish, the authors used morpholino-mediated knockdown of the transcription 
factor pu.1 to prevent microglial development. This morpholino had no effect on the 
number of dopaminergic neurons in pink1-/- fish compared to uninjected pink1-/- fish. 
This failure to rescue the lower numbers of Th+ neurons in pink1-/- larvae suggested 
that the microglial phenotype is a result of dying Th+ neurons, rather than an upstream 
mechanism which leads to reduced numbers of Th+ neurons. However, sufficient 
evidence that the morpholino affected the numbers of microglial cells in these fish is 
not provided.  
Interestingly, pink1-/- mice have similar numbers of Th+ neurons to wildtype control 
mice, but they too exhibit a microglial phenotype, which precedes dopaminergic 
deficits. Levels of il-1β, il-12, and il-10 were increased in the striatum of pink1-/- mice 
injected with the immunostimulant lipopolysaccharide (LPS) compared to wildtype 
mice also injected with LPS (Akundi et al. 2011). Furthermore, the only post-mortem 
report from a patient with two mutations in pink1 mentions a moderate microgliosis 
(Samaranch et al. 2010). As this is relatively common among patients with 
neurodegenerative diseases it is often assumed that this is a result of neuronal cell 
death. However, as pink1 is ubiquitously expressed it is possible that pink1 mutations 
result in a microglial phenotype which is not caused by dopaminergic cell death. This 
could help to explain why I observed a microglial phenotype in pink1-/- fish but no 
difference in the number of Th+ neurons.  
5.3.2 Chemogenetic ablation of dopaminergic neurons 
The results presented here show overlapping but different patterns of GFP+ cells and 
Th+ cells in the brains of otpb:NTR-GFP adult zebrafish (Figure 5. 3). This 
corresponds to previous results in larvae (Lambert et al. 2012). For example, GFP+ 
cells are found in population 12 and the locus coeruleus, the Th+ neurons whose 




Metronidazole treatment did not lead to a reduction in GFP+ cells in adult zebrafish 
(Figure 5. 4, Figure 5. 5). I immersed fish in 10 mM metronidazole, a concentration 
which has been shown to be sufficient to ablate cells in the CNS of adult zebrafish 
(Agetsuma et al. 2010; Soares Godoy 2015), although different lines are known to 
require different concentrations of metronidazole to induce cell death (Curado et al. 
2008). Immersion of adult fish in concentrations higher than 10 mM metronidazole 
has been reported to increase mortality (Soares Godoy 2015), and for this reason I 
did not test higher concentrations. In an attempt to increase the availability of 
metronidazole to neurons in the fish I injected metronidazole intraperitoneally, 
however, this was also unsuccessful in ablating GFP+ cells (Figure 5. 5).   
I assessed the success of ablation by the presence of GFP fluorescence in the spinal 
cord in metronidazole treated and vehicle treated fish. It has previously been shown 
that cells which contribute to the dopaminergic diencephalic tract (DDT) are otpb+ (Tay 
et al. 2011a; Ryu et al. 2007; Lambert et al. 2012). Therefore, successful ablation of 
otpb:NTR-GFP cells in the brain would dramatically reduce the amount of GFP+ axons 
in the spinal cord.  
It is possible that the lack of ablation is due to a reduction in the copy number of the 
transgene over several generations of breeding. Although the copy number may be 
high enough to detect fluorescence in which the transgene is expressed (Godoy et al. 
2015), expression levels may not by high enough to metabolise metronidazole and 
cause cell death.    
There are other zebrafish lines which express NTR in dopaminergic neurons. For 
example, a line has been created in which CFP-NTR is expressed in cells expressing 
the dopamine transporter (dat) (Godoy et al. 2015; Soares Godoy 2015). Double 




telencephalon, PPa/PPp, PVO, PPr, and diencephalon. However, while 
metronidazole treatment did reduce the level of CFP in the brain by up to 80%, there 
was no difference in the level of Th, measured by western blotting with whole brain 
homogenate. This suggests that the majority of Th+ neurons in the adult zebrafish 
were not successfully ablated in these fish. Nonetheless, cell counts showed 
metronidazole treated fish had fewer Th+ neurons in the olfactory bulb. Furthermore, 
the numbers of CFP+ cells, Th+ cells, and Th+/CFP+ cells were recovered to vehicle 
treated levels by 45 days post metronidazole treatment. This was accompanied by an 
increased number of BrdU+/CFP+ cells in one region of the olfactory bulb 45 days post 
treatment. Together these results indicate that Th+ cells of the olfactory bulb can be 
regenerated in the adult zebrafish brain, but that these fish may not be suitable to 
assess the regenerative capacity of other populations of Th+ neurons due to 
unsuccessful ablation. 
Another line expresses NTR under the control of the Th promoter (Fernandes et al. 
2012).  Metronidazole treatment of Tg(BAC th:Gal4VP16)m1233; Tg(UAS-E1b:NfsB-
mCherry)c294 larvae has been reported to ablate dopaminergic neurons in diencephalic 
groups 2 and 4 at 7 dpf, although the quantification of Th+ cells indicated variable 
efficiency of the ablation. However, this driver line does not drive expression in all 
cells labelled by Th immunohistochemistry, and several areas of ectopic expression 
have been observed (Haehnel-Taguchi et al. 2018). In the NTR line the pattern of 
mCherry expression was not shown, so it is not possible to determine which other Th+ 
populations expressed the NTR transcript. In the future, the overlap of mCherry+ cells 
in the adult brain of these fish could be compared to Th+ cells detected by 
immunohistochemistry to determine which populations express NTR. Treating these 




whether these fish would be a useful tool for the ablation of Th+ neurons in the adult 
zebrafish brain.   
5.3.3 Chemical ablation of dopaminergic neurons: MPTP and MPP+ 
The results I have presented here show we were unable to ablate Th+ neurons in the 
adult zebrafish brain using MPTP and MPP+ (Figure 5. 6, Figure 5. 7, Table 5. 1). This 
is in accordance with published results showing MPTP injections into adult zebrafish 
do not affect the numbers of Th+ cells in the brain (Anichtchik et al. 2003; Bretaud et 
al. 2004). Although this is in contrast to the selective degeneration of Th+ neurons 
reported in other species, there is known variation in the toxicity of MPTP between 
species (Speciale 2002; Langston 2017). 
A key factor for MPTP-mediated ablation of dopaminergic neurons is the availability 
of monoamine oxidases (MAOs), the enzymes responsible for the conversion of 
MPTP into the toxic metabolite MPP+. One explanation that has been suggested for 
this variability between species is the different levels of expression of MAO at the 
blood brain barrier. Rats, which are remarkably resistant to MPTP neurotoxicity, have 
very high levels of MAO at the blood brain barrier, and so systemically administered 
MPTP is converted into MPP+ at the blood brain barrier. As MPP+ is not lipophilic it 
cannot permeate the blood brain barrier, preventing the toxic compound from 
reaching the brain (Riachi et al. 1988; Riachi et al. 1989). In comparison, MAO is 
expressed to a lesser degree at the blood brain barrier in mice, and mice are 
moderately affected by MPTP, because some MPTP reaches the brain unconverted 
(Heikkila et al. 1984).  Humans are most susceptible to MPTP, and, in line with this 
theory, human microvessels were the poorest in converting MPTP to MPP+ (Riachi et 
al. 1988; Langston 2017). Although the level of MAO at the blood brain barrier in the 
adult zebrafish is not known, quantitative RT-PCR showed that MAO is expressed in 




liver (Anichtchik et al. 2006). This could explain why MPTP has been shown to cause 
peripheral effects in adult zebrafish such as quickened opercular movements and 
darkened skin pigmentation (Bretaud et al. 2004). Furthermore, in situ hybridisation 
was used to compare the expression of MAO in different areas of the adult zebrafish 
brain, and surprisingly low levels of expression were found around dopaminergic 
populations (Anichtchik et al. 2006). In contrast, noradrenergic neurons of the locus 
coeruleus contained relatively high levels of MAO (Anichtchik et al. 2006). Taken 
together, these findings suggest that the location of MAO may protect dopaminergic 
neurons in the adult zebrafish brain from MPTP-induced cell death.  
To circumvent the problems associated with the conversion of MPTP into MPP+, we 
injected MPP+ directly into the brain, but this was also unsuccessful in ablating Th+ 
neurons (Figure 5. 6, Figure 5. 7). Injection of MPP+ has been shown to cause 
peripheral effects in zebrafish, including altered opercular movements (Bretaud et al. 
2004). Therefore it is possible that the concentration needed to kill dopaminergic 
neurons in the adult zebrafish brain is higher than the concentration at which 
peripheral effects of MPP+ become lethal.  
I assessed whether successful ablation of Th+ neurons was achieved by assessing 
the Th+ immunoreactivity in the spinal cord and the number of Th+ cell in the locus 
coeruleus (Figure 5. 6, Figure 5. 7). However, it is possible that other Th+ populations 
were affected by MPTP/MPP+ while these populations were unaffected. Detailed cell 
counts of each individual population would determine whether this is the case.  
The four most commonly used chemicals to induce dopaminergic cell death in animal 
models are 6OHDA, MPTP, rotenone, and paraquat (Bové et al. 2005). Rotenone and 
paraquat are pesticides implicated in the pathogenesis of Parkinson’s disease (Le 




zebrafish brain after 4 weeks of treatment (Bretaud et al. 2004). Hence 6OHDA is 
currently the only chemical which has been shown to reproducibly ablate Th+ neurons  
in the adult zebrafish brain (Caldwell and Davies et al. 2018; Vijayanathan et al. 2017; 
Matsui et al. 2017). 
5.4 Conclusions 
In this chapter I attempted to find an alternative method to 6OHDA to ablate Th+ 
neurons in the zebrafish brain. pink1-/- larvae had no difference in the numbers of Th+ 
cells during development, although I did observe an increase in the numbers of 4C4+ 
cells. Tg(otpb:NTR-GFP) zebrafish had double positive Th+/GFP+ cells in populations 
of Th+ neurons which are vulnerable to 6OHDA, however, I observed no ablation with 
metronidazole treatment. Thirdly, I tried injecting fish with MPTP and MPP+, but I did 





Chapter Six: Investigating the Regeneration of 
Interneurons in the Spinal Cord 
6.1 Introduction 
6.1.1 Neuronal diversity in the zebrafish spinal cord  
The neuronal circuitry of the spinal cord contains a number of different types of 
neurons. Anatomical observations of the zebrafish spinal cord have led to the 
classification of neurons based on their cellular morphology, axonal projections, and 
location (Figure 6. 1, (Bernhardt et al. 1992; Hale et al. 2001)). Neurons can also be 
grouped according to their neurotransmitter phenotype, as this often correlates with 
its functional role in the spinal cord circuitry, e.g. acetylcholine can be used to identify 
motor neurons. The majority of excitatory interneurons in the spinal cord are 
glutamatergic, while GABAergic neurons represent some of the main inhibitory 
neurons.  
 
Figure 6. 1 A summary of the diversity of interneurons in the zebrafish spinal cord at 4-5 dpf, 
adapted from (Lewis & Eisen 2003). CoSA: Commissural Secondary Ascending neurons, CoPA: 
Commissural Primary Ascending neurons, UCoD: Unipolar Commissural Descending neurons, 
CoBL: Commissural Bifurcating Longitudinal neurons, CiD: Circumferential Descending neurons, 
VeMe: Ventral Medial neurons, CoLA: Commissural Longitudinal Ascending, MCoD: Multipolar 
Commissural Descending neurons, DoLA: Dorsal Longitudinal Ascending neurons, KA: Kolmer-
Agduhr neurons. 
6.1.1.1. GABAergic neurons in the zebrafish spinal cord 
GABAergic neurons can be detected by the presence of glutamate decarboxylase 




al. 1998). A combination of in situ hybridisation for gad1 and immunohistochemistry 
for GABA has been used to identify GABAergic neurons in the zebrafish spinal cord. 
Both markers have been shown to have near identical distribution, indicating that gad1 
is a suitable marker for GABAergic neurons in zebrafish (Higashijima, Mandel, et al. 
2004). Of the several different types of interneurons which have been described in 
the developing spinal cord (Hale et al. 2001), four have been shown to be GABAergic 
in embryos, namely Dorsal Longitudinal Ascending (DoLA) neurons, Commissural 
Secondary Ascending (CoSA) neurons, Ventral Longitudinal Descending (VeLD) 
neurons, and  Kolmer-Agduhr (KA) neurons ((Bernhardt et al. 1992), Figure 6. 1). In 
the larval zebrafish, the distribution of gad1 expression correlates with the same cell 
types (Higashijima, Mandel, et al. 2004), and both DoLA and KA neurons have been 
confirmed to be GABAergic at 4-5 dpf by α-GABA immunolabelling (Higashijima, 
Schaefer, et al. 2004). While suspected technical difficulties in backfilling these 
neurons has prevented the identification of the exact cell types of GABAergic neurons 
in the dorsal and medial gad1 expression domains (Higashijima, Schaefer, et al. 2004), 
extrapolating from GABAergic neurons found in embryos it is likely these cells are 
VeLDs and/or CoSAs.  
6.1.1.2. Glutamatergic neurons in the zebrafish spinal cord 
Glutamatergic neurons can be identified by the presence of vesicular glutamate 
transporters, which utilise the proton gradient to load glutamate into synaptic vesicles 
(Fremeau et al. 2004; Takamori et al. 2000). Previous studies indicate that the 
majority of glutamatergic neurons express vglut2 (Fremeau et al. 2004; Herzog et al. 
2004). Based on location and cellular morphology, six different types of vglut2a+ 
interneurons have been identified in the larval zebrafish spinal cord, including 
Circumferential Descending (CiD) interneurons, Multipolar Commissural Descending 




Medial (VeMe) interneurons, Commissural Primary Ascending (CoPA) interneurons, 
and glutamatergic Commissural Secondary Ascending (CoSA) interneurons (Figure 
6. 1), in addition to sensory Rohon Beard neurons (Hale et al. 2001; Higashijima, 
Schaefer, et al. 2004; Higashijima, Mandel, et al. 2004).  
The creation of fluorescent reporter lines in which RFP or GFP is driven by 
neurotransmitter-specific promoters has provided further insights into the relative 
distributions of GABAergic and glutamatergic neurons in the zebrafish spinal cord 
(Satou et al. 2013). Consistent with previous in situ hybridisation and immunostaining 
(Higashijima, Schaefer, et al. 2004; Higashijima, Mandel, et al. 2004), these lines 
showed that vglut2a+ and gad1b+ neurons are distinct populations in the larval 
zebrafish spinal cord (Satou et al. 2013).  These lines represent useful tools for 
investigating the distribution of GABAergic and glutamatergic neurons in the adult 
zebrafish spinal cord. 
 
6.1.2. Neurogenesis in zebrafish spinal cord regeneration 
6.1.2.1. Adult zebrafish spinal cord regeneration 
Following complete transection of the spinal cord adult zebrafish are able to recover 
function and regain normal swimming capacity by six weeks post lesion (Becker et al. 
2004; Reimer et al. 2008). 
A spinal cord lesion induces neuronal cell death, and successful regeneration involves 
the replacement of these neurons. New neurons are generated from ependymo-radial 
glial cells (ERGs), which have a soma contacting the ventricle and long processes 
extending to the pial edge (Becker & Becker 2015). In the unlesioned adult spinal cord 
ERGs are essentially quiescent, demonstrated by very low numbers of PCNA+ and 




lesion site to proliferate and generate new neurons to replace those which have been 
lost, shown by an increase in PCNA+ and BrdU+ cells at the ventricle from 3 -14 dpl 
(Reimer et al. 2008).  
At least some of these new neurons are motor neurons, demonstrated by the 
presence of BrdU+ cells at 2 wpl which are also HB9:GFP+ and/or islet-1:GFP+ 
(Reimer et al. 2008), markers of differentiating motor neurons (Flanagan-Steet et al. 
2005; Higashijima et al. 2000). However, fewer than 8% of BrdU labelled cells at 2 
wpl also express markers for motor neurons (Reimer et al. 2008), indicating that other 
neuronal subtypes may also be produced in the lesioned adult spinal cord. Moreover, 
lesion-induced proliferation is not restricted to ERGs in the motor neuron progenitor 
domain, as PCNA+ cells are seen surrounding the entire central canal (Reimer et al. 
2008). Previous studies have discovered that a range of neuronal subtypes are 
regenerated in zebrafish after a spinal cord lesion (Kuscha, Frazer, et al. 2012; 
Kuscha, Barreiro-Iglesias, et al. 2012). The various neuronal subtypes which have 
been shown to be newly generated after a spinal cord lesion in adult zebrafish are 
summarised in Figure 6. 2. However, it is still unclear whether GABAergic and 





Figure 6. 2 Summary of different neuronal subtypes previously shown to be newly generated in 
the lesioned spinal cord of adult zebrafish, illustrated on a schematic cross-section. 5-HT+ 
(serotonergic) neurons (Kuscha, Barreiro-Iglesias, et al. 2012), motor neurons (Reimer et al. 2008; 
Reimer et al. 2009), V2 cells (Kuscha, Frazer, et al. 2012), and Pax2+ interneurons (Kuscha, Frazer, 
et al. 2012) have been demonstrated to be newly generated after a spinal cord lesion. Taken from 
(Kuscha, Frazer, et al. 2012).  
6.1.2.2  Larval zebrafish spinal cord regeneration 
Similarly, larval zebrafish lesioned at 3 days post-fertilisation (dpf) can regenerate 
their spinal cord and recover normal swimming behaviour by 2 days post-lesion (dpl) 
(Ohnmacht et al. 2016).  At this stage of development, ERGs around the central canal 
are still proliferative, but the majority of neurogenesis is completed by 3 dpf (Park et 
al. 2007). The number of newly generated motor neurons (HB9:GFP+/EdU+ cells) is 
increased two days after a lesion compared to unlesioned age-matched controls 
(Ohnmacht et al. 2016), demonstrating that there is a lesion-induced increase in 
neurogenesis in order to replace neurons which have been lost. However, the extent 
to which different neuronal subtypes are replaced after a spinal cord lesion in larval 
zebrafish has not been fully elucidated.  
In this chapter I aim to investigate the localisation of glutamatergic and GABAergic 
neurons in the adult zebrafish spinal cord, and assess the capacity to regenerate 
these neuronal subtypes following a spinal cord lesion in both larvae and adults.  
6.2 Results 
6.2.1 gad1b+ neurons are regenerated after a lesion 
6.2.1.1 The number of newly generated gad1b:RFP+ neurons is increased in 
lesioned larvae 
I assessed the formation of new GABAergic neurons in the spinal cord of larval 
zebrafish at 5 dpf with and without a lesion using a transgenic line in which gab1b+ 
neurons are labelled with RFP (Satou et al. 2013). Larvae were lesioned at 3 dpf and 




neurons (EdU+/RFP+ cells) was significantly higher in lesioned animals compared to 
unlesioned fish (unlesioned: 0.7778 ± 0.2222, lesioned: 2.444 ± 0.2422, Figure 6. 3), 
indicating that GABAergic neurons can be regenerated after a spinal cord injury.  
 
Figure 6. 3 gad1b:RFP+ neurons are regenerated following a spinal cord lesion in the larval 
zebrafish. A: The experimental timeline is shown. B: Single optical sections showing EdU+ and 
RFP+ cells in the spinal cord around the lesion site, with double labelled cells indicated by the 
arrows (lateral view, rostral left). C: Zoomed in images showing an EdU+/RFP+ cell. D: 
Quantification showing the numbers of EdU+/RFP+ cells. Mann Whitney U test, ** p < 0.01. Scale 
bar in B = 50 µm, scale bar in C = 10 µm. 
 
6.2.1.2 Lesion-induced gad1b:RFP+ neurogenesis in the adult spinal cord 
To determine whether gad1b+ neurons could also be regenerated in the adult spinal 
cord, I injected fish with EdU at 3 and 6 days post-lesion (dpl) and counted the 
numbers of EdU+/RFP+ cells at 14 dpl. Double labelled cells were never observed in 




wpl: 35.83 ± 5.388). This demonstrates that there is lesion-induced neurogenesis of 
GABAergic neurons following a spinal cord lesion in adult zebrafish.  
 
Figure 6. 4 gad1b:RFP+ neurons are regenerated after an injury to the adult zebrafish spinal cord. 
A: The experimental timeline is given. B: Maximal projections showing EdU+ cells and RFP+ cells 
in coronal sections of the adult zebrafish spinal cord, with zoomed in images of single sections 
around central canal. The arrow indicates a EdU+/RFP+ cell close to the central canal. D: 





6.2.2 Vglut2a:GFP+ neurons are regenerated after a lesion 
6.2.2.1 The number of newly generated vglut2a:GFP+ neurons is increased in 
lesioned larvae 
I assessed the formation of new glutamatergic neurons in the spinal cord of larval 
zebrafish at 5 dpf with and without a lesion using a transgenic line in which vglut2a+ 
neurons are labelled with GFP (Satou et al. 2013). Larvae were lesioned at 3 dpf and 
immersed in EdU until histology at 5 dpf (Figure 6. 5A). Double labelled GFP+/EdU+ 
cells were rarely observed in control animals, suggesting the majority of glutamatergic 
neurogenesis is completed by 3 dpf. The number of new vglut2a:GFP+ neurons 
(EdU+/GFP+) neurons was significantly higher in lesioned animals compared to 
unlesioned fish (unlesioned: 0.2500 ± 0.1637, lesioned: 3.444 ± 0.3768, Figure 6. 5), 





Figure 6. 5 Vglut2a:GFP+ neurons are regenerated following a spinal cord lesion in the larval 
zebrafish. A: The experimental timeline is shown. B: Maximum projections showing EdU+ and 
GFP+ cells in the spinal cord around the lesion site, with double labelled cells indicated by the 
arrows (lateral view, rostral left). C: Zoomed in images showing an EdU+/GFP+ cell. D: 
Quantification showing the numbers of EdU+/GFP+ cells. Mann Whitney U test, *** p < 0.001. Scale 
bar in B = 50 µm, scale bar in C = 10 µm. 
6.2.2.2 No newly generated vglut2a:GFP+ neurons were found in the adult 
zebrafish spinal cord  
To determine whether vglut2a+ neurons could also be regenerated in the adult spinal 
cord, I injected fish with EdU at 3 and 6 dpl and counted the numbers of EdU+/RFP+ 
cells at 14 dpl (Figure 6. 6A). In the dorsal area of the spinal cord GFP+ cells were 
observed in both conditions, but were not present in every section. These were 




direction. Large cell bodies were also found close to the central canal, with long axons 
extending diagonally outwards. No double labelled GFP+/EdU+ cells were observed 
in the unlesioned (n=4) or the lesioned spinal cord (n=3).  
To better understand the pattern of GFP labelling in adult zebrafish I collaborated with 
Cristina Gonzalez Martinez to obtain images of the intact spinal cord without 
sectioning the tissue. The cleared tissue allowed us to view up to just over one 
hemisection of the spinal cord (Figure 6. 6C). Using Imaris software we were able to 
rotate the 3D reconstruction, and this verified that the dorsal spinal cord contained 
GFP+ axons projecting in a rostral-caudal direction. Cells were visible along these 
axons, however they were relatively heterogeneously distributed, with up to 100 µm 
with no cells. In the ventral spinal cord, we observed thick axons running in a rostral-
caudal direction in the ventral lateral corner of the spinal cord, with axons extending 





Figure 6. 6 vglut2a:GFP+ neurons in the adult zebrafish spinal cord. A: The experimental timeline 
for B is shown. B: Maximum projections showing EdU+ and GFP+ cells in coronal sections of the 
adult spinal cord, with zoomed in images of single sections around the central canal. No double 
labelled GFP+/EdU+ cells were observed in either condition. C: Images of the adult spinal cord 
showing the distribution of vglut2a:GFP+ axons and cells from a lateral view (left rostral) and 








6.3.1 gad1b:RFP+ neurons are present around the central canal in the adult 
zebrafish spinal cord, and are newly generated after a spinal cord lesion 
gad1b:RFP+ cells were observed close to the central canal in the adult zebrafish 
spinal cord (Figure 6. 4). Based on their position in the spinal cord these appear to be 
Kolmer-Agduhr (KA) neurons, which have been described previously in the 
developing zebrafish spinal cord (Bernhardt et al. 1992; Martin et al. 1998; 
Higashijima, Schaefer, et al. 2004).  
In this chapter I have demonstrated that a spinal cord lesion induces neurogenesis of 
gad1b:RFP+ neurons in the adult zebrafish spinal cord (Figure 6. 4). This indicates 
that GABAergic neurons are regenerated in addition to the other neuronal subtypes 
already shown to be regenerated in the adult zebrafish spinal cord (Figure 6. 2, 
(Reimer et al. 2008; Kuscha, Frazer, et al. 2012; Kuscha, Barreiro-Iglesias, et al. 
2012)).  A previous PhD student (Veronika Kuscha) reported a trend for increased 
GABAergic interneurons after a lesion ((unlesioned: 576.15 ± 47.20, n = 3; 2 wpl: 
621.46 ± 7.18, n = 2)(Kuscha 2011)) , however, this did not reach statistical 
significance, and no BrdU+/GABA+ cells were observed in either unlesioned or 
lesioned spinal cords at 2 wpl. Future experiments could use the gad1b:RFP+ reporter 
line in combination with immunohistochemistry for GABA to determine whether the 
two labels completely overlap in the adult spinal cord, as has been demonstrated in 
the developing spinal cord (Higashijima, Mandel, et al. 2004).  
In the adult zebrafish brain, GABAergic neurons have been shown to be newly 
generated following excitotoxic injury (Skaggs et al. 2014). Genetic lineage tracing 




experiments could use a similar approach to establish whether newly generated 
GABAergic neurons are also derived from her4+ progenitor cells in the spinal cord.  
Immunohistochemistry for the postsynaptic protein SV2 has confirmed that 
regenerated motor neurons make synaptic contacts, demonstrating that they can 
integrate into the existing neuronal circuitry (Reimer et al. 2008). Applying the same 
method and looking for overlap between SV2 labelling and GABAergic neurons would 
determine whether these neurons also establish synaptic connections.  
6.3.2 vglut2a:GFP+ neurons are present in the adult zebrafish spinal cord 
The GFP labelling in the spinal cord of vglut2a:GFP+ fish showed that there are 
vglut2a+ neurons and axons in the adult zebrafish spinal cord. However, no 
GFP+/EdU+ cells were observed in either the unlesioned or lesioned spinal cords, 
suggesting that vglut2a+ neurons are not newly generated in the adult zebrafish spinal 
cord, even after a spinal cord lesion. However, it is possible that vglut2a+ 
neurogenesis does occur, but at a lower level than other neuronal subtypes, thus 
making it less likely to observe vglut2a+:GFP+/EdU+ cells. The low density of GFP+ 
cells meant there were several sections with no GFP+ cells at all, and this combined 
with the limited bioavailability of EdU means the probability of observing a double 
labelled cell may be very low, even if they do exist. Future experiments could look to 
repeat this experiment with more fish, and use the tissue clearing to view a larger area 
of the whole spinal cord rather than individual 50 µm sections. In addition, increasing 
the number of EdU injections would label more proliferating ERGs, and therefore give 
a higher chance of detecting any newly generated vglut2a+ neurons.  
In the developing zebrafish spinal cord, vglut2a+ neurons have been shown to be 
derived from dorsal progenitor domains, including pd1, pd3, and pd4/5 (Satou et al. 




progenitor domains, for example pax3 and pax7, are not expressed after a lesion (Dr. 
Veronika Kuscha, unpublished). In contrast, genes expressed in the ventral progenitor 
domains during development, for example olig2, nkx6.1, and pax6, showed increased 
expression following a lesion in adult zebrafish spinal cord (Reimer et al. 2009). All of 
the neurons which have been shown to be regenerated after a spinal cord lesion in 
adult zebrafish are derived from ventral progenitor domains (Figure 6.2, (Reimer et al. 
2008; Kuscha, Barreiro-Iglesias, et al. 2012; Kuscha, Frazer, et al. 2012). This 
suggests that the different capacity to regenerate neurons after a spinal cord lesion 
may be a reflection of the dorso-ventral location of the progenitor domains from which 
neurons are derived during development. 
Future experiments could investigate whether the vglut2a:GFP+ axonal projections 
are regenerated following a spinal cord lesion. The majority of GFP+ axons I observed 
in the adult spinal cord ran in a rostral-caudal direction (Figure 6.6), and so must be 
disrupted by a complete transection of the spinal cord. The regeneration of axons is 
essential for the re-establishment of neuronal circuity and functional recovery (Becker 
et al. 1997). Tissue clearing could be used to obtain a lateral view of the tissue 
bridging the lesion site to determine whether vglut2a:GFP+ axons are able to regrow 
across the lesion site. This could then be used in combination with 
immunohistochemistry for synaptic markers, such as SV2, to identify any 
vglut2a:GFP+ axons successfully bridging the lesion site and making synaptic 
contacts.  
6.3.3 Glutamatergic and GABAergic interneurons are newly generated 
following a spinal cord lesion in larval zebrafish 
Here I demonstrate for the first time that there is a lesion-induced increase in newly 
formed gad1b:RFP+ and vglut2a:GFP+ interneurons in the larval zebrafish spinal cord 




experiments suggest that neurogenesis of these cell types is largely complete by 3 
dpf, consistent with previous observations. The results presented here align with 
previous publications showing glutamatergic neurons are regenerated after a spinal 
cord injury in lamprey  (Fernández-López et al. 2016), suggesting this capability is not 
species-specific.  
In a similar model of spinal cord injury, in which larval zebrafish were lesioned at 5 
dpf and analysed at time points up to 9 dpi, proliferation of ERGs in the p0 progenitor 
domain was increased in lesioned fish compared to sham controls (Briona & Dorsky 
2014b). This domain is defined by expression of dbx1, and both glutamatergic 
neurons and GABAergic neurons are derived from this population of progenitor cells 
during embryogenesis (Satou et al. 2012). Approximately 75% of newly generated 
neurons (BrdU+/HuC/D+ cells) in the proximal zone were also dbx1a:GFP+ (Briona & 
Dorsky 2014b), indicating that the majority of newly generated neurons produced after 
a spinal cord lesion are derived from this progenitor domain. However, it is not known 
whether this domain also generates both glutamatergic and GABAergic neurons after 
a lesion. Future experiments could employ genetic lineage tracing to learn more about 
the progenitor cells responsible for the newly generated neurons. Zebrafish lines have 
been created in which Cre is specifically expressed in cells in particular progenitor 
domains of the spinal cord, and these have been used in combination with 
Tg(gad1b:loxP-RFP-loxP-GFP) and Tg(vglut2a:loxP-GFP-loxP-RFP) lines to 
successfully determine the origin of interneurons during development (Satou et al. 
2013; Kani et al. 2010).  Replacing the constitutively active Cre with an inducible form 
would allow for temporal control. Immersing these larvae in 4OHT at the time of injury 
could determine which progenitor domains proliferate in response to the lesion and 




As discussed in the introduction to this chapter, there are several different types of 
glutamatergic and GABAergic neurons in the larval zebrafish spinal cord (Figure 6. 1), 
and the fluorescent reporter lines I used do not discriminate between these classes 
of neurons. Neuronal cell bodies were clearly visible in the images I obtained (Figure 
6. 3, Figure 6. 5), but the axonal projections of individual cells could not be followed 
due to relatively weaker fluorescent signal in the axonal projections and the high 
density of neuronal cell bodies. This prevented the identification of different types of 
interneurons labelled by each line (Hale et al. 2001). Future experiments could aim to 
determine which classes of glutamatergic and GABAergic interneurons are 
regenerated after a spinal cord lesion. Labelling only newly generated neurons, for 
example using genetic lineage tracing with inducible drivers, would produce a sparser 
labelling of neurons. This could increase the ability to evaluate the axonal projections 
of newly generated neurons and determine which types of interneurons are newly 
generated after a lesion. 
6.4 Conclusions 
In larvae, a spinal cord lesion induces an increase in the numbers of newly generated 
GABAergic and glutamatergic neurons. In adult zebrafish, GABAergic neurons are 
found in the medial spinal cord close to the central canal, and at least some are 
regenerated following a spinal cord lesion. Glutamatergic neurons are found in the 
dorsal spinal cord, with the majority of axons projecting in a rostral-caudal direction. I 
found no evidence of regenerated glutamatergic neurons in adult zebrafish following 






Chapter Seven: General Discussion 
In this thesis I investigated which populations of neurons are capable of being 
regenerated in the zebrafish central nervous system, which cells give rise to 
regenerated neurons, and the signalling pathways involved in their regeneration. 
Through genetic lineage tracing I was able to determine the origin of dopaminergic 
neurons formed after 6OHDA-induced ablation of Th+ cells. I also investigated the 
involvement of signalling pathways in the successful regeneration of dopaminergic 
neurons. I then attempted to find an alternative method to ablate Th+ neurons in the 
zebrafish brain. Finally, I investigated the extent to which glutamatergic and 
GABAergic neurons are regenerated after a spinal cord lesion.  
7.1 Investigating the Origin of New Th+ Neurons in the Adult Zebrafish Brain 
In investigating the origin of Th+ neurons in the adult zebrafish brain I found that cells 
lining the diencephalic ventricle display the morphology of ERGs, and described the 
heterogeneity of these cells in terms of their expression of gfap, olig2, and her4. Using 
genetic lineage tracing I showed that new Th+ neurons can be generated from her4+ 
ERGs at the diencephalic ventricle. 
Neurogenesis in the adult rodent brain is thought to be restricted to the olfactory bulb, 
the subventricular zone (SVZ) of the lateral ventricles in the telencephalon and the 
subgranular zone (SGZ) of the dentate gyrus in the hippocampus (Altman & Das 1965; 
Altman 1969; Bergmann et al. 2015). However, there have been reports of newly 
generated neurons in other areas, including the area of the brain affected by 
Parkinson’s disease in humans. Investigations into whether new Th+ neurons can be 
found in the substantia nigra have delivered conflicting results, and, as a result, 
whether new Th+ neurons are added to the mammalian substantia nigra in adulthood 




2007). BrdU+/Th+ cells have been detected in the substantia nigra of adult mice, 
although the number of double-labelled cells was very low, which the authors suggest 
may be one of the reasons they have been overlooked by others (Zhao et al. 2003). 
The new Th+ neurons were shown to be derived from cells at the ventricle, which 
express markers of neural stem cells (Zhao et al. 2003; Shan et al. 2006). This 
suggests that there may be similarities in the cells from which Th+ neurons originate 
in the mammalian brain and in salamanders and zebrafish, species which are capable 
of successful regeneration of Th+ neurons. Therefore further investigation into the 
genes expressed by ERGs giving rise to Th+ neurons in zebrafish could help to identify 
a pool of progenitor cells in the adult mammalian brain which could be stimulated to 
replace Th+ neurons lost in Parkinson’s disease. However, it should be noted that the 
population of Th+ neurons investigated here (population 5/6) is not considered to be 
equivalent to the substantia nigra (Kaslin and Panula 2001; Rink and Wullimann 2001), 
and that despite the replacement of dopaminergic neurons in this population the 
functional deficits observed after 6OHDA-induced ablation of Th+ neurons observed 
in behavioural studies are not recovered (Caldwell and Davies et al. 2018). This is 
likely a consequence of the permanent loss of descending axonal projections from 
the locus coeruleus and population 12, which provide the only catecholaminergic 
innervation of the spinal cord.  
Having established the origin of new Th+ cells in the brain, future work could 
investigate the fate of new Th+ neurons generated after 6OHDA-induced ablation of 
dopaminergic neurons. For successful neuroregeneration it is necessary for neurons 
to make synaptic contacts and integrate into the existing neural circuitry. Analysis of 
a terminal field ventral to population 5/6 found that the axon density in 6OHDA-
injected fish was reduced in 6OHDA injected fish compared to uninjected controls 




fish at 42 dpi and 180 dpi, when cell numbers have recovered. However, the axon 
density did reach control levels at 540 dpi. This indicates that there is a slow 
restoration of axonal projections from population 5/6 after neurons are replaced. To 
investigate  whether newly formed neurons successfully integrate into the existing 
circuitry, one could look for the presence of new Th + neurons colabelled with markers 
of synaptic contacts, for example SV2. Interestingly, both the newly generated Th+ 
neurons found in the mouse brain and Th+ neurons derived from stem cell 
transplanted into the brains of Parkinson’s disease patients have been shown to 
innervate the correct target structures and form synapses, indicating successful 
integration into the existing neuronal circuitry (Kriks et al. 2011; Grealish et al. 2014; 
Kikuchi et al. 2017; Grealish et al. 2015; Zhao et al. 2003).  
7.2 Investigating the Signalling Pathways Involved in the Regeneration 
of Th+ Neurons 
I investigated whether several different signalling pathways are involved in the 
regeneration of Th+ neurons in the adult zebrafish brain. The results I presented in 
chapter 4 demonstrate that ablation of Th+ neurons elicited an immune response, and 
also increased the number of proliferating ERGs at the diencephalic ventricle. 
Following on from this, I showed that this ablation-induced immune response is 
necessary but not sufficient for successful regeneration of Th+ neurons.  
Subsequently, I investigated the effects of three molecular signals on ERG 
proliferation and the production of Th+ neurons. However, I did not observe any effect 
of LTC4, the dopamine receptor antagonist haloperidol, or the tnf-α signalling inhibitor 
pomalidomide, on the number of proliferating ERGs at the diencephalic ventricle, or 
on Th+ neurogenesis. Future work could focus on elucidating the mechanism through 
which microglial activation influences ERG proliferation, identifying which molecules 




Others have also shown that the immune system plays a crucial role in the successful 
regeneration of the CNS (Kyritsis et al. 2012; Tsarouchas et al. 2018; Bollaerts et al. 
2017; Bhattarai et al. 2016). Interestingly, neuroinflammation appears to promote 
regeneration in a number of different ways. Here I showed that an immune response 
increases neurogenesis, which is important for the replacement of neurons. However, 
there is growing evidence that activation of the immune system can also improve 
axonal regeneration (Bollaerts et al. 2017). Intravitreal injection of zymosan has been 
shown to promote the retinal ganglion cell axonal regeneration in zebrafish and 
rodents (Becker et al. 2000; Leon et al. 2000; Lorber et al. 2005). In the zebrafish 
spinal cord, stimulating an immune response with lipopolysaccharide (LPS) was 
shown to increase the percentage of fish with axons bridging the lesion site 
(Tsarouchas et al. 2018). Furthermore, immune activation promotes the integration of 
new neurons into the existing neuronal circuity. Intrahippocampal injection of LPS 
resulted in larger clusters of postsynaptic receptors on the dendrites of new neurons 
in the rat brain, indicating successful integration into the neuronal circuitry (Jakubs et 
al. 2008).  
The pro-regenerative effects of immune stimulation could inspire future treatments for 
CNS diseases and injuries. Immune activation is known to be involved in a range of 
neurodegenerative diseases, as well as stroke, traumatic brain injury, and spinal cord 
injuries (Joshi & Singh 2018; Clayton et al. 2017; Herranz et al. 2016; Lehnardt 2009). 
Stimulation of the immune system can promote regeneration in all areas of the CNS. 
Therefore, further investigation into the relationship between immune activation and 
CNS repair could lead to the development of treatments with the potential to improve 




7.3 Investigating Alternative Methods of Th+ Neuron Ablation 
In order to assess the regenerative capacity of Th+ populations unaffected by 6OHDA 
I investigated the potential of using other methods of ablation. I found no difference in 
the numbers of Th+ neurons in pink1-/- larvae compared to pink1+/+ larvae, and did not 
achieve successful ablation with either chemogenetic ablation or injections of MPTP 
or MPP+. Hence 6OHDA remains the most reproducible method of ablating Th+ 
neuron in the adult zebrafish brain (Caldwell and Davies et al. 2018; Vijayanathan et 
al. 2017; Matsui et al. 2017). 
7.4 Investigating the Regeneration of Interneurons in the Spinal Cord 
Finally, I investigated the regenerative capacity of glutamatergic and GABAergic 
neurons in the spinal cord in adult and larval zebrafish after a spinal cord injury. I 
found that both glutamatergic and GABAergic neurogenesis are increased after a 
spinal cord lesion in larvae, and GABAergic neurons are regenerated after a spinal 
cord lesion in the adult spinal cord. Future work could focus on the origin of these 
newly generated cells, and aim to identify which progenitor domains are responsible 
for producing these new cells after a lesion. Furthermore, immunohistochemistry for 
the postsynaptic protein SV2 combined with labelled glutamatergic and GABAergic 
neurons could determine whether these new neurons also establish synaptic 
connections and thus integrate into the existing neuronal circuitry. 
In the mammalian spinal cord neurogenesis stops during development and is not 
induced by a spinal cord injury. However, replacing neurons lost after an injury has 
been shown to promote functional recovery. Neural stem cells derived from embryonic 
rat spinal cord were expanded in vitro, labelled with BrdU, and transplanted into adult 
rat spinal cords injured by contusion (Ogawa et al. 2002). After five weeks, these cells 
had differentiated into a range of cell types, including astrocytes, oligodendrocytes, 




their integration into the existing neuronal circuitry. Furthermore, behavioural testing 
showed that the transplants improved functional recovery from the injury. This shows 
that there is potential for cell replacement therapy to restore function and improve 
outcomes for patients with spinal cord injuries.  
Investigations into the successful regeneration of neurons in the zebrafish spinal cord 
have already identified a number of different signalling pathways which involved in 
the replacement of neurons and regrowth of axons, leading to functional recovery 
(Barreiro-Iglesias et al. 2015; Wehner et al. 2017; Reimer et al. 2013). This could 
inform future experiments in mammals with the aim of improving neuronal 
replacement after injury either through transplantation of exogenous stem cells or 
through promoting neurogenesis from endogenous stem cell populations.  
7.5 Overall remarks 
Overall, the results I have presented in this thesis add to our current understanding of 
the extent to which zebrafish are capable of replacing neurons of the CNS, and of 
how this is achieved. Ultimately, a greater understanding of the regeneration of 
neurons in the CNS could help to inform future strategies to improve 
neuroregeneration in mammals. This could potentially be useful in developing new 
treatments for neurodegenerative disease such as Parkinson’s, as well as physical 
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